
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-01-19 05:03:39 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='loss', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/phrase_4_0.5_tag_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.2, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[8e-06], lr_scheduler='inverse_sqrt', max_epoch=50, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=4096, max_tokens_valid=4096, max_update=0, maximize_best_checkpoint_metric=False, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='../checkpoints/EMEA_p_5', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=1e-07)
2021-01-19 05:03:40 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-01-19 05:03:40 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-01-19 05:03:40 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.de
2021-01-19 05:03:40 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/valid.de-en.en
2021-01-19 05:03:40 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA valid de-en 151 examples
2021-01-19 05:03:44 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-01-19 05:03:44 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-01-19 05:03:44 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-01-19 05:03:49 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-01-19 05:03:49 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-19 05:03:49 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-01-19 05:03:49 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-01-19 05:03:49 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-01-19 05:03:49 | INFO | fairseq_cli.train | max tokens per GPU = 4096 and max sentences per GPU = None
2021-01-19 05:03:53 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-01-19 05:03:53 | INFO | fairseq.trainer | loading train data for epoch 1
2021-01-19 05:03:53 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.de
2021-01-19 05:03:53 | INFO | fairseq.data.data_utils | loaded 93981 examples from: ../../../data-bin/phrase_4_0.5_tag_EMEA/train.de-en.en
2021-01-19 05:03:53 | INFO | fairseq.tasks.translation | ../../../data-bin/phrase_4_0.5_tag_EMEA train de-en 93981 examples
2021-01-19 05:03:54 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-19 05:03:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-01-19 05:03:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-01-19 05:03:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-01-19 05:03:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-01-19 05:03:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 4.0
2021-01-19 05:04:01 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 2.0
2021-01-19 05:04:15 | INFO | train_inner | epoch 001:    106 / 324 loss=3.967, nll_loss=2.312, ppl=4.96, wps=19674.3, ups=5.13, wpb=3837.1, bsz=288.5, num_updates=100, lr=2e-07, gnorm=30.851, loss_scale=3, train_wall=19, wall=26
2021-01-19 05:04:34 | INFO | train_inner | epoch 001:    206 / 324 loss=3.238, nll_loss=1.466, ppl=2.76, wps=19753.8, ups=5.13, wpb=3847.8, bsz=286.2, num_updates=200, lr=4e-07, gnorm=13.454, loss_scale=2, train_wall=19, wall=46
2021-01-19 05:04:54 | INFO | train_inner | epoch 001:    306 / 324 loss=2.863, nll_loss=1.043, ppl=2.06, wps=19905, ups=5.19, wpb=3835.2, bsz=295.7, num_updates=300, lr=6e-07, gnorm=4.753, loss_scale=2, train_wall=19, wall=65
2021-01-19 05:04:57 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:04:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:04:58 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:04:59 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:04:59 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:04:59 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:04:59 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:05:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). In the studies, actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated hemoglobin (HbA1c), which indicates how well the blood sugar is regulated. What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:05:02 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:05:02 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.943 | nll_loss 2.228 | ppl 4.68 | bleu 34.12 | wps 919.6 | wpb 1083 | bsz 37.8 | num_updates 318
2021-01-19 05:05:02 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:05:17 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 1 @ 318 updates, score 3.943) (writing took 14.690603285096586 seconds)
2021-01-19 05:05:17 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-01-19 05:05:17 | INFO | train | epoch 001 | loss 3.329 | nll_loss 1.576 | ppl 2.98 | wps 15025.6 | ups 3.92 | wpb 3837.5 | bsz 289.8 | num_updates 318 | lr 6.36e-07 | gnorm 15.623 | loss_scale 3 | train_wall 63 | wall 88
2021-01-19 05:05:17 | INFO | fairseq_cli.train | begin training epoch 1
2021-01-19 05:05:32 | INFO | train_inner | epoch 002:     82 / 324 loss=2.786, nll_loss=0.97, ppl=1.96, wps=9867.2, ups=2.58, wpb=3821.8, bsz=285.8, num_updates=400, lr=8e-07, gnorm=3.005, loss_scale=2, train_wall=19, wall=104
2021-01-19 05:05:52 | INFO | train_inner | epoch 002:    182 / 324 loss=2.585, nll_loss=0.753, ppl=1.69, wps=20045.8, ups=5.17, wpb=3877, bsz=296.6, num_updates=500, lr=1e-06, gnorm=2.01, loss_scale=2, train_wall=19, wall=123
2021-01-19 05:06:11 | INFO | train_inner | epoch 002:    282 / 324 loss=2.533, nll_loss=0.705, ppl=1.63, wps=19680.1, ups=5.17, wpb=3803.4, bsz=284.4, num_updates=600, lr=1.2e-06, gnorm=1.613, loss_scale=2, train_wall=19, wall=142
2021-01-19 05:06:19 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:06:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:06:20 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:06:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-01-19 05:06:20 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:06:21 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy A rapid improvement in blood sugar control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:06:21 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:06:24 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients). In the studies, actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated. What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:06:24 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:06:24 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 3.874 | nll_loss 2.166 | ppl 4.49 | bleu 34.84 | wps 932.3 | wpb 1083 | bsz 37.8 | num_updates 642 | best_loss 3.874
2021-01-19 05:06:24 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:06:42 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 2 @ 642 updates, score 3.874) (writing took 18.60255677625537 seconds)
2021-01-19 05:06:42 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-01-19 05:06:42 | INFO | train | epoch 002 | loss 2.596 | nll_loss 0.769 | ppl 1.7 | wps 14518.3 | ups 3.78 | wpb 3838.4 | bsz 290.1 | num_updates 642 | lr 1.284e-06 | gnorm 2.034 | loss_scale 2 | train_wall 62 | wall 173
2021-01-19 05:06:42 | INFO | fairseq_cli.train | begin training epoch 2
2021-01-19 05:06:53 | INFO | train_inner | epoch 003:     58 / 324 loss=2.439, nll_loss=0.604, ppl=1.52, wps=9083.8, ups=2.36, wpb=3854, bsz=300.1, num_updates=700, lr=1.4e-06, gnorm=1.32, loss_scale=2, train_wall=19, wall=185
2021-01-19 05:07:13 | INFO | train_inner | epoch 003:    158 / 324 loss=2.523, nll_loss=0.703, ppl=1.63, wps=19589.9, ups=5.22, wpb=3752, bsz=276.1, num_updates=800, lr=1.6e-06, gnorm=1.503, loss_scale=2, train_wall=19, wall=204
2021-01-19 05:07:32 | INFO | train_inner | epoch 003:    258 / 324 loss=2.412, nll_loss=0.579, ppl=1.49, wps=20100.6, ups=5.14, wpb=3907.1, bsz=296.9, num_updates=900, lr=1.8e-06, gnorm=1.172, loss_scale=2, train_wall=19, wall=223
2021-01-19 05:07:45 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:07:45 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:07:45 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:07:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:07:46 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:07:47 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - peripheral neuropathy A rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:07:47 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:07:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a study with 182 patients). In the studies, Actrapid was compared to a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated. What benefit did actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-01-19 05:07:49 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:07:49 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 3.785 | nll_loss 2.065 | ppl 4.19 | bleu 36.79 | wps 976.1 | wpb 1083 | bsz 37.8 | num_updates 966 | best_loss 3.785
2021-01-19 05:07:49 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:08:06 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 3 @ 966 updates, score 3.785) (writing took 17.2824309268035 seconds)
2021-01-19 05:08:06 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-01-19 05:08:06 | INFO | train | epoch 003 | loss 2.456 | nll_loss 0.628 | ppl 1.55 | wps 14776.8 | ups 3.85 | wpb 3838.4 | bsz 290.1 | num_updates 966 | lr 1.932e-06 | gnorm 1.306 | loss_scale 2 | train_wall 62 | wall 258
2021-01-19 05:08:06 | INFO | fairseq_cli.train | begin training epoch 3
2021-01-19 05:08:13 | INFO | train_inner | epoch 004:     34 / 324 loss=2.439, nll_loss=0.612, ppl=1.53, wps=9378.9, ups=2.44, wpb=3838.4, bsz=291.6, num_updates=1000, lr=2e-06, gnorm=1.29, loss_scale=2, train_wall=19, wall=264
2021-01-19 05:08:32 | INFO | train_inner | epoch 004:    134 / 324 loss=2.378, nll_loss=0.543, ppl=1.46, wps=19967.2, ups=5.14, wpb=3881.1, bsz=292.8, num_updates=1100, lr=2.2e-06, gnorm=1.019, loss_scale=2, train_wall=19, wall=284
2021-01-19 05:08:52 | INFO | train_inner | epoch 004:    234 / 324 loss=2.376, nll_loss=0.543, ppl=1.46, wps=19759.7, ups=5.17, wpb=3825, bsz=288.3, num_updates=1200, lr=2.4e-06, gnorm=1.079, loss_scale=2, train_wall=19, wall=303
2021-01-19 05:09:09 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:09:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:09:10 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:09:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:09:10 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:09:11 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:09:11 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:09:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a study with 182 patients). In the studies, Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated. What benefit did Actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-01-19 05:09:14 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:09:14 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 3.712 | nll_loss 1.979 | ppl 3.94 | bleu 38.9 | wps 936.7 | wpb 1083 | bsz 37.8 | num_updates 1290 | best_loss 3.712
2021-01-19 05:09:14 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:09:30 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 4 @ 1290 updates, score 3.712) (writing took 16.294208040926605 seconds)
2021-01-19 05:09:30 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-01-19 05:09:30 | INFO | train | epoch 004 | loss 2.388 | nll_loss 0.556 | ppl 1.47 | wps 14883.6 | ups 3.88 | wpb 3838.4 | bsz 290.1 | num_updates 1290 | lr 2.58e-06 | gnorm 1.105 | loss_scale 2 | train_wall 62 | wall 341
2021-01-19 05:09:30 | INFO | fairseq_cli.train | begin training epoch 4
2021-01-19 05:09:32 | INFO | train_inner | epoch 005:     10 / 324 loss=2.387, nll_loss=0.556, ppl=1.47, wps=9514.5, ups=2.49, wpb=3821.1, bsz=285.6, num_updates=1300, lr=2.6e-06, gnorm=1.106, loss_scale=2, train_wall=19, wall=343
2021-01-19 05:09:51 | INFO | train_inner | epoch 005:    110 / 324 loss=2.35, nll_loss=0.514, ppl=1.43, wps=19802.3, ups=5.18, wpb=3824.2, bsz=286.9, num_updates=1400, lr=2.8e-06, gnorm=0.959, loss_scale=2, train_wall=19, wall=363
2021-01-19 05:10:11 | INFO | train_inner | epoch 005:    210 / 324 loss=2.329, nll_loss=0.492, ppl=1.41, wps=19882.1, ups=5.18, wpb=3841.9, bsz=292.6, num_updates=1500, lr=3e-06, gnorm=0.958, loss_scale=2, train_wall=19, wall=382
2021-01-19 05:10:30 | INFO | train_inner | epoch 005:    310 / 324 loss=2.34, nll_loss=0.506, ppl=1.42, wps=19872.8, ups=5.15, wpb=3855.2, bsz=293.2, num_updates=1600, lr=3.2e-06, gnorm=1.051, loss_scale=2, train_wall=19, wall=401
2021-01-19 05:10:33 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:10:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:10:33 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:10:34 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:10:34 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:10:35 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:10:35 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:10:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a study with 182 patients). In the studies, Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well the glucose is regulated. What benefit did Actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-01-19 05:10:37 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:10:37 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 3.668 | nll_loss 1.925 | ppl 3.8 | bleu 39.87 | wps 917.6 | wpb 1083 | bsz 37.8 | num_updates 1614 | best_loss 3.668
2021-01-19 05:10:37 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:10:55 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 5 @ 1614 updates, score 3.668) (writing took 17.579796819016337 seconds)
2021-01-19 05:10:55 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-01-19 05:10:55 | INFO | train | epoch 005 | loss 2.344 | nll_loss 0.509 | ppl 1.42 | wps 14657.2 | ups 3.82 | wpb 3838.4 | bsz 290.1 | num_updates 1614 | lr 3.228e-06 | gnorm 1.003 | loss_scale 2 | train_wall 62 | wall 426
2021-01-19 05:10:55 | INFO | fairseq_cli.train | begin training epoch 5
2021-01-19 05:11:11 | INFO | train_inner | epoch 006:     86 / 324 loss=2.342, nll_loss=0.507, ppl=1.42, wps=9179.7, ups=2.41, wpb=3809, bsz=285.6, num_updates=1700, lr=3.4e-06, gnorm=1.047, loss_scale=2, train_wall=19, wall=443
2021-01-19 05:11:31 | INFO | train_inner | epoch 006:    186 / 324 loss=2.286, nll_loss=0.446, ppl=1.36, wps=19999, ups=5.15, wpb=3885, bsz=296.2, num_updates=1800, lr=3.6e-06, gnorm=0.81, loss_scale=2, train_wall=19, wall=462
2021-01-19 05:11:50 | INFO | train_inner | epoch 006:    286 / 324 loss=2.361, nll_loss=0.53, ppl=1.44, wps=19566.9, ups=5.21, wpb=3754, bsz=282.7, num_updates=1900, lr=3.8e-06, gnorm=1.122, loss_scale=2, train_wall=19, wall=481
2021-01-19 05:11:58 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:11:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:11:58 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:11:59 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:11:59 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:12:00 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:12:00 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:12:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a study with 182 patients). In the studies, Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well glucose is regulated. What benefit did Actrapid show in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-01-19 05:12:02 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:12:02 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 3.648 | nll_loss 1.897 | ppl 3.72 | bleu 39.94 | wps 919.2 | wpb 1083 | bsz 37.8 | num_updates 1938 | best_loss 3.648
2021-01-19 05:12:02 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:12:20 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 6 @ 1938 updates, score 3.648) (writing took 18.04041440691799 seconds)
2021-01-19 05:12:20 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-01-19 05:12:20 | INFO | train | epoch 006 | loss 2.311 | nll_loss 0.474 | ppl 1.39 | wps 14580.5 | ups 3.8 | wpb 3838.4 | bsz 290.1 | num_updates 1938 | lr 3.876e-06 | gnorm 0.934 | loss_scale 2 | train_wall 62 | wall 511
2021-01-19 05:12:20 | INFO | fairseq_cli.train | begin training epoch 6
2021-01-19 05:12:32 | INFO | train_inner | epoch 007:     62 / 324 loss=2.273, nll_loss=0.433, ppl=1.35, wps=9264.5, ups=2.38, wpb=3900.1, bsz=292.6, num_updates=2000, lr=4e-06, gnorm=0.819, loss_scale=2, train_wall=19, wall=523
2021-01-19 05:12:52 | INFO | train_inner | epoch 007:    162 / 324 loss=2.265, nll_loss=0.423, ppl=1.34, wps=19270.7, ups=5.02, wpb=3840.4, bsz=291.8, num_updates=2100, lr=4.2e-06, gnorm=0.874, loss_scale=2, train_wall=20, wall=543
2021-01-19 05:13:12 | INFO | train_inner | epoch 007:    262 / 324 loss=2.315, nll_loss=0.479, ppl=1.39, wps=19492.5, ups=5.14, wpb=3790.4, bsz=279.2, num_updates=2200, lr=4.4e-06, gnorm=0.989, loss_scale=2, train_wall=19, wall=563
2021-01-19 05:13:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:13:24 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:13:24 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:13:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:13:25 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:13:26 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:13:26 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:13:28 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well glucose control is. What benefit did Actrapid show in these trials? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-01-19 05:13:28 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:13:28 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 3.635 | nll_loss 1.883 | ppl 3.69 | bleu 40.92 | wps 919.4 | wpb 1083 | bsz 37.8 | num_updates 2262 | best_loss 3.635
2021-01-19 05:13:28 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:13:46 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 7 @ 2262 updates, score 3.635) (writing took 18.035825208295137 seconds)
2021-01-19 05:13:46 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-01-19 05:13:46 | INFO | train | epoch 007 | loss 2.282 | nll_loss 0.443 | ppl 1.36 | wps 14443.4 | ups 3.76 | wpb 3838.4 | bsz 290.1 | num_updates 2262 | lr 4.524e-06 | gnorm 0.898 | loss_scale 2 | train_wall 63 | wall 597
2021-01-19 05:13:46 | INFO | fairseq_cli.train | begin training epoch 7
2021-01-19 05:13:54 | INFO | train_inner | epoch 008:     38 / 324 loss=2.243, nll_loss=0.401, ppl=1.32, wps=9230.6, ups=2.38, wpb=3880.4, bsz=302.6, num_updates=2300, lr=4.6e-06, gnorm=0.756, loss_scale=2, train_wall=19, wall=605
2021-01-19 05:14:13 | INFO | train_inner | epoch 008:    138 / 324 loss=2.263, nll_loss=0.425, ppl=1.34, wps=20040, ups=5.18, wpb=3869.4, bsz=297.7, num_updates=2400, lr=4.8e-06, gnorm=0.91, loss_scale=2, train_wall=19, wall=624
2021-01-19 05:14:32 | INFO | train_inner | epoch 008:    238 / 324 loss=2.246, nll_loss=0.402, ppl=1.32, wps=19656.2, ups=5.17, wpb=3800.9, bsz=282.6, num_updates=2500, lr=5e-06, gnorm=0.847, loss_scale=2, train_wall=19, wall=644
2021-01-19 05:14:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:14:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:14:49 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:14:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:14:50 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:14:51 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:14:51 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:14:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates how well glucose control is. What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-01-19 05:14:53 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:14:53 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 3.625 | nll_loss 1.87 | ppl 3.66 | bleu 40.84 | wps 924.4 | wpb 1083 | bsz 37.8 | num_updates 2586 | best_loss 3.625
2021-01-19 05:14:53 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:15:11 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 8 @ 2586 updates, score 3.625) (writing took 17.202614904846996 seconds)
2021-01-19 05:15:11 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-01-19 05:15:11 | INFO | train | epoch 008 | loss 2.257 | nll_loss 0.416 | ppl 1.33 | wps 14722.4 | ups 3.84 | wpb 3838.4 | bsz 290.1 | num_updates 2586 | lr 5.172e-06 | gnorm 0.857 | loss_scale 2 | train_wall 62 | wall 682
2021-01-19 05:15:11 | INFO | fairseq_cli.train | begin training epoch 8
2021-01-19 05:15:13 | INFO | train_inner | epoch 009:     14 / 324 loss=2.25, nll_loss=0.408, ppl=1.33, wps=9348.4, ups=2.43, wpb=3853.3, bsz=288.9, num_updates=2600, lr=5.2e-06, gnorm=0.834, loss_scale=2, train_wall=19, wall=685
2021-01-19 05:15:33 | INFO | train_inner | epoch 009:    114 / 324 loss=2.251, nll_loss=0.411, ppl=1.33, wps=19957.7, ups=5.18, wpb=3855.1, bsz=293, num_updates=2700, lr=5.4e-06, gnorm=0.89, loss_scale=2, train_wall=19, wall=704
2021-01-19 05:15:52 | INFO | train_inner | epoch 009:    214 / 324 loss=2.22, nll_loss=0.373, ppl=1.29, wps=19703.3, ups=5.16, wpb=3817.3, bsz=282.2, num_updates=2800, lr=5.6e-06, gnorm=0.727, loss_scale=2, train_wall=19, wall=723
2021-01-19 05:16:11 | INFO | train_inner | epoch 009:    314 / 324 loss=2.237, nll_loss=0.396, ppl=1.32, wps=19909.4, ups=5.19, wpb=3838, bsz=295.1, num_updates=2900, lr=5.8e-06, gnorm=0.849, loss_scale=2, train_wall=19, wall=743
2021-01-19 05:16:13 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:16:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:16:14 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:16:15 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:16:15 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:16:15 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:16:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:16:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1 954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring for six months the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well glucose is controlled. What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6 month treatment with Actrapid.
2021-01-19 05:16:18 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:16:18 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 3.624 | nll_loss 1.866 | ppl 3.65 | bleu 42.02 | wps 922.4 | wpb 1083 | bsz 37.8 | num_updates 2910 | best_loss 3.624
2021-01-19 05:16:18 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:16:37 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_best.pt (epoch 9 @ 2910 updates, score 3.624) (writing took 18.74691059719771 seconds)
2021-01-19 05:16:37 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-01-19 05:16:37 | INFO | train | epoch 009 | loss 2.235 | nll_loss 0.391 | ppl 1.31 | wps 14468.5 | ups 3.77 | wpb 3838.4 | bsz 290.1 | num_updates 2910 | lr 5.82e-06 | gnorm 0.826 | loss_scale 2 | train_wall 62 | wall 768
2021-01-19 05:16:37 | INFO | fairseq_cli.train | begin training epoch 9
2021-01-19 05:16:54 | INFO | train_inner | epoch 010:     90 / 324 loss=2.207, nll_loss=0.36, ppl=1.28, wps=8988.8, ups=2.33, wpb=3850.2, bsz=289.4, num_updates=3000, lr=6e-06, gnorm=0.736, loss_scale=2, train_wall=19, wall=786
2021-01-19 05:17:14 | INFO | train_inner | epoch 010:    190 / 324 loss=2.208, nll_loss=0.362, ppl=1.29, wps=19819, ups=5.17, wpb=3836.2, bsz=293.7, num_updates=3100, lr=6.2e-06, gnorm=0.793, loss_scale=2, train_wall=19, wall=805
2021-01-19 05:17:33 | INFO | train_inner | epoch 010:    290 / 324 loss=2.222, nll_loss=0.377, ppl=1.3, wps=19877.3, ups=5.18, wpb=3835.4, bsz=287.4, num_updates=3200, lr=6.4e-06, gnorm=0.766, loss_scale=2, train_wall=19, wall=824
2021-01-19 05:17:39 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:17:40 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:17:40 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:17:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:17:41 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:17:42 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:17:42 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:17:44 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well glucose is controlled. What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6 month treatment with Actrapid.
2021-01-19 05:17:44 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:17:44 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 3.634 | nll_loss 1.879 | ppl 3.68 | bleu 42.55 | wps 937.5 | wpb 1083 | bsz 37.8 | num_updates 3234 | best_loss 3.624
2021-01-19 05:17:44 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:17:49 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 10 @ 3234 updates, score 3.634) (writing took 5.296859135385603 seconds)
2021-01-19 05:17:49 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-01-19 05:17:49 | INFO | train | epoch 010 | loss 2.213 | nll_loss 0.368 | ppl 1.29 | wps 17134.3 | ups 4.46 | wpb 3838.4 | bsz 290.1 | num_updates 3234 | lr 6.468e-06 | gnorm 0.772 | loss_scale 2 | train_wall 62 | wall 840
2021-01-19 05:17:49 | INFO | fairseq_cli.train | begin training epoch 10
2021-01-19 05:18:02 | INFO | train_inner | epoch 011:     66 / 324 loss=2.209, nll_loss=0.363, ppl=1.29, wps=13129.3, ups=3.44, wpb=3815.8, bsz=287.9, num_updates=3300, lr=6.6e-06, gnorm=0.806, loss_scale=2, train_wall=19, wall=853
2021-01-19 05:18:21 | INFO | train_inner | epoch 011:    166 / 324 loss=2.187, nll_loss=0.338, ppl=1.26, wps=19695.6, ups=5.15, wpb=3827, bsz=288.4, num_updates=3400, lr=6.8e-06, gnorm=0.702, loss_scale=2, train_wall=19, wall=873
2021-01-19 05:18:41 | INFO | train_inner | epoch 011:    266 / 324 loss=2.191, nll_loss=0.344, ppl=1.27, wps=19893.1, ups=5.17, wpb=3851.3, bsz=292.2, num_updates=3500, lr=7e-06, gnorm=0.74, loss_scale=2, train_wall=19, wall=892
2021-01-19 05:18:52 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:18:52 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:18:52 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:18:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:18:53 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:18:54 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:18:54 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:18:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). In the trials, Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well glucose is controlled. What benefit has Actrapid shown in these trials? Concentrations of HbA1c remained relatively stable during the 6 month treatment with Actrapid.
2021-01-19 05:18:56 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:18:56 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 3.641 | nll_loss 1.892 | ppl 3.71 | bleu 43.26 | wps 922.4 | wpb 1083 | bsz 37.8 | num_updates 3558 | best_loss 3.624
2021-01-19 05:18:56 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:19:02 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 11 @ 3558 updates, score 3.641) (writing took 5.493791043758392 seconds)
2021-01-19 05:19:02 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-01-19 05:19:02 | INFO | train | epoch 011 | loss 2.195 | nll_loss 0.348 | ppl 1.27 | wps 17090.4 | ups 4.45 | wpb 3838.4 | bsz 290.1 | num_updates 3558 | lr 7.116e-06 | gnorm 0.753 | loss_scale 2 | train_wall 62 | wall 913
2021-01-19 05:19:02 | INFO | fairseq_cli.train | begin training epoch 11
2021-01-19 05:19:10 | INFO | train_inner | epoch 012:     42 / 324 loss=2.202, nll_loss=0.356, ppl=1.28, wps=13105.3, ups=3.4, wpb=3850.6, bsz=293.7, num_updates=3600, lr=7.2e-06, gnorm=0.826, loss_scale=2, train_wall=19, wall=921
2021-01-19 05:19:30 | INFO | train_inner | epoch 012:    142 / 324 loss=2.172, nll_loss=0.322, ppl=1.25, wps=19948.8, ups=5.16, wpb=3867, bsz=293.8, num_updates=3700, lr=7.4e-06, gnorm=0.718, loss_scale=2, train_wall=19, wall=941
2021-01-19 05:19:49 | INFO | train_inner | epoch 012:    242 / 324 loss=2.167, nll_loss=0.317, ppl=1.25, wps=19898.3, ups=5.17, wpb=3852.4, bsz=296.5, num_updates=3800, lr=7.6e-06, gnorm=0.691, loss_scale=2, train_wall=19, wall=960
2021-01-19 05:20:05 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:20:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:20:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:20:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:20:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:20:07 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:20:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:20:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance known as glycosylated haemoglobin (HbA1c), which indicates glycaemic control. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:20:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:20:09 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 3.659 | nll_loss 1.912 | ppl 3.76 | bleu 42.89 | wps 934.2 | wpb 1083 | bsz 37.8 | num_updates 3882 | best_loss 3.624
2021-01-19 05:20:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:20:15 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 12 @ 3882 updates, score 3.659) (writing took 5.411443662829697 seconds)
2021-01-19 05:20:15 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-01-19 05:20:15 | INFO | train | epoch 012 | loss 2.178 | nll_loss 0.329 | ppl 1.26 | wps 17130.2 | ups 4.46 | wpb 3838.4 | bsz 290.1 | num_updates 3882 | lr 7.764e-06 | gnorm 0.73 | loss_scale 2 | train_wall 62 | wall 986
2021-01-19 05:20:15 | INFO | fairseq_cli.train | begin training epoch 12
2021-01-19 05:20:18 | INFO | train_inner | epoch 013:     18 / 324 loss=2.198, nll_loss=0.35, ppl=1.27, wps=13030.8, ups=3.42, wpb=3807.1, bsz=279.7, num_updates=3900, lr=7.8e-06, gnorm=0.776, loss_scale=2, train_wall=19, wall=989
2021-01-19 05:20:38 | INFO | train_inner | epoch 013:    118 / 324 loss=2.147, nll_loss=0.294, ppl=1.23, wps=19902.1, ups=5.15, wpb=3862.7, bsz=292.5, num_updates=4000, lr=8e-06, gnorm=0.609, loss_scale=2, train_wall=19, wall=1009
2021-01-19 05:20:57 | INFO | train_inner | epoch 013:    218 / 324 loss=2.185, nll_loss=0.335, ppl=1.26, wps=19882, ups=5.17, wpb=3842.3, bsz=287.5, num_updates=4100, lr=7.90184e-06, gnorm=0.832, loss_scale=2, train_wall=19, wall=1028
2021-01-19 05:21:16 | INFO | train_inner | epoch 013:    318 / 324 loss=2.15, nll_loss=0.298, ppl=1.23, wps=19591, ups=5.17, wpb=3789.4, bsz=288.1, num_updates=4200, lr=7.8072e-06, gnorm=0.636, loss_scale=2, train_wall=19, wall=1047
2021-01-19 05:21:17 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:21:18 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:21:18 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:21:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:21:19 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:21:20 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:21:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:21:22 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood sugar is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:21:22 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:21:22 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 3.703 | nll_loss 1.961 | ppl 3.89 | bleu 43.56 | wps 908.9 | wpb 1083 | bsz 37.8 | num_updates 4206 | best_loss 3.624
2021-01-19 05:21:22 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:21:28 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 13 @ 4206 updates, score 3.703) (writing took 6.155323532875627 seconds)
2021-01-19 05:21:28 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-01-19 05:21:28 | INFO | train | epoch 013 | loss 2.162 | nll_loss 0.311 | ppl 1.24 | wps 16909.3 | ups 4.41 | wpb 3838.4 | bsz 290.1 | num_updates 4206 | lr 7.80163e-06 | gnorm 0.697 | loss_scale 2 | train_wall 62 | wall 1059
2021-01-19 05:21:28 | INFO | fairseq_cli.train | begin training epoch 13
2021-01-19 05:21:46 | INFO | train_inner | epoch 014:     94 / 324 loss=2.153, nll_loss=0.301, ppl=1.23, wps=12758.1, ups=3.32, wpb=3841.8, bsz=283.4, num_updates=4300, lr=7.71589e-06, gnorm=0.657, loss_scale=2, train_wall=19, wall=1078
2021-01-19 05:22:06 | INFO | train_inner | epoch 014:    194 / 324 loss=2.151, nll_loss=0.297, ppl=1.23, wps=19620.5, ups=5.17, wpb=3792.9, bsz=284.7, num_updates=4400, lr=7.6277e-06, gnorm=0.7, loss_scale=2, train_wall=19, wall=1097
2021-01-19 05:22:25 | INFO | train_inner | epoch 014:    294 / 324 loss=2.144, nll_loss=0.292, ppl=1.22, wps=20105.6, ups=5.16, wpb=3895.2, bsz=300.5, num_updates=4500, lr=7.54247e-06, gnorm=0.68, loss_scale=2, train_wall=19, wall=1116
2021-01-19 05:22:31 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:22:31 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:22:31 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:22:32 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:22:32 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:22:33 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:22:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:22:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c concentrations remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:22:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:22:35 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 3.719 | nll_loss 1.985 | ppl 3.96 | bleu 43.08 | wps 918.7 | wpb 1083 | bsz 37.8 | num_updates 4530 | best_loss 3.624
2021-01-19 05:22:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:22:42 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 14 @ 4530 updates, score 3.719) (writing took 6.604501495603472 seconds)
2021-01-19 05:22:42 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-01-19 05:22:42 | INFO | train | epoch 014 | loss 2.149 | nll_loss 0.296 | ppl 1.23 | wps 16838.2 | ups 4.39 | wpb 3838.4 | bsz 290.1 | num_updates 4530 | lr 7.51746e-06 | gnorm 0.677 | loss_scale 2 | train_wall 62 | wall 1133
2021-01-19 05:22:42 | INFO | fairseq_cli.train | begin training epoch 14
2021-01-19 05:22:56 | INFO | train_inner | epoch 015:     70 / 324 loss=2.133, nll_loss=0.279, ppl=1.21, wps=12505, ups=3.27, wpb=3824.6, bsz=294.3, num_updates=4600, lr=7.46004e-06, gnorm=0.603, loss_scale=2, train_wall=19, wall=1147
2021-01-19 05:23:15 | INFO | train_inner | epoch 015:    170 / 324 loss=2.132, nll_loss=0.278, ppl=1.21, wps=20032.7, ups=5.16, wpb=3879.6, bsz=295.8, num_updates=4700, lr=7.38025e-06, gnorm=0.653, loss_scale=2, train_wall=19, wall=1166
2021-01-19 05:23:34 | INFO | train_inner | epoch 015:    270 / 324 loss=2.143, nll_loss=0.29, ppl=1.22, wps=19759.3, ups=5.18, wpb=3817.3, bsz=286.4, num_updates=4800, lr=7.30297e-06, gnorm=0.708, loss_scale=2, train_wall=19, wall=1186
2021-01-19 05:23:45 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:23:45 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:23:45 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:23:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:23:46 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:23:47 | INFO | fairseq.tasks.translation | example hypothesis: Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:23:47 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:23:49 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c concentrations remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:23:49 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:23:49 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 3.73 | nll_loss 1.994 | ppl 3.98 | bleu 43.13 | wps 914.6 | wpb 1083 | bsz 37.8 | num_updates 4854 | best_loss 3.624
2021-01-19 05:23:49 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:23:56 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 15 @ 4854 updates, score 3.73) (writing took 7.001411458011717 seconds)
2021-01-19 05:23:56 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-01-19 05:23:56 | INFO | train | epoch 015 | loss 2.137 | nll_loss 0.284 | ppl 1.22 | wps 16729.3 | ups 4.36 | wpb 3838.4 | bsz 290.1 | num_updates 4854 | lr 7.26223e-06 | gnorm 0.659 | loss_scale 2 | train_wall 62 | wall 1208
2021-01-19 05:23:56 | INFO | fairseq_cli.train | begin training epoch 15
2021-01-19 05:24:05 | INFO | train_inner | epoch 016:     46 / 324 loss=2.142, nll_loss=0.287, ppl=1.22, wps=12149.8, ups=3.24, wpb=3747.6, bsz=272.9, num_updates=4900, lr=7.22806e-06, gnorm=0.667, loss_scale=2, train_wall=19, wall=1216
2021-01-19 05:24:24 | INFO | train_inner | epoch 016:    146 / 324 loss=2.122, nll_loss=0.267, ppl=1.2, wps=20087.9, ups=5.17, wpb=3886.6, bsz=295.8, num_updates=5000, lr=7.15542e-06, gnorm=0.631, loss_scale=2, train_wall=19, wall=1236
2021-01-19 05:24:44 | INFO | train_inner | epoch 016:    246 / 324 loss=2.149, nll_loss=0.296, ppl=1.23, wps=20082.2, ups=5.17, wpb=3885.9, bsz=293.7, num_updates=5100, lr=7.08492e-06, gnorm=0.704, loss_scale=2, train_wall=19, wall=1255
2021-01-19 05:24:59 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:24:59 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:24:59 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:25:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:25:00 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:25:01 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:25:01 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:25:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c concentrations remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:25:03 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:25:03 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 3.762 | nll_loss 2.037 | ppl 4.1 | bleu 42.76 | wps 977.4 | wpb 1083 | bsz 37.8 | num_updates 5178 | best_loss 3.624
2021-01-19 05:25:03 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:25:09 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 16 @ 5178 updates, score 3.762) (writing took 5.74791336292401 seconds)
2021-01-19 05:25:09 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-01-19 05:25:09 | INFO | train | epoch 016 | loss 2.128 | nll_loss 0.274 | ppl 1.21 | wps 17112.7 | ups 4.46 | wpb 3838.4 | bsz 290.1 | num_updates 5178 | lr 7.03135e-06 | gnorm 0.637 | loss_scale 2 | train_wall 62 | wall 1280
2021-01-19 05:25:09 | INFO | fairseq_cli.train | begin training epoch 16
2021-01-19 05:25:13 | INFO | train_inner | epoch 017:     22 / 324 loss=2.1, nll_loss=0.244, ppl=1.18, wps=12988.1, ups=3.39, wpb=3830.1, bsz=296.2, num_updates=5200, lr=7.01646e-06, gnorm=0.499, loss_scale=2, train_wall=19, wall=1285
2021-01-19 05:25:33 | INFO | train_inner | epoch 017:    122 / 324 loss=2.116, nll_loss=0.261, ppl=1.2, wps=19974.6, ups=5.14, wpb=3883.7, bsz=295, num_updates=5300, lr=6.94996e-06, gnorm=0.575, loss_scale=2, train_wall=19, wall=1304
2021-01-19 05:25:52 | INFO | train_inner | epoch 017:    222 / 324 loss=2.129, nll_loss=0.275, ppl=1.21, wps=19841.8, ups=5.19, wpb=3824.3, bsz=283.6, num_updates=5400, lr=6.8853e-06, gnorm=0.675, loss_scale=2, train_wall=19, wall=1323
2021-01-19 05:26:11 | INFO | train_inner | epoch 017:    322 / 324 loss=2.126, nll_loss=0.272, ppl=1.21, wps=19679.2, ups=5.18, wpb=3796.7, bsz=289.2, num_updates=5500, lr=6.82242e-06, gnorm=0.638, loss_scale=2, train_wall=19, wall=1343
2021-01-19 05:26:12 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:26:12 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:26:12 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:26:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:26:13 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:26:14 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:26:14 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:26:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (one trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c concentrations remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:26:16 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:26:16 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 3.77 | nll_loss 2.045 | ppl 4.13 | bleu 42.82 | wps 922 | wpb 1083 | bsz 37.8 | num_updates 5502 | best_loss 3.624
2021-01-19 05:26:16 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:26:22 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 17 @ 5502 updates, score 3.77) (writing took 5.415850182063878 seconds)
2021-01-19 05:26:22 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-01-19 05:26:22 | INFO | train | epoch 017 | loss 2.12 | nll_loss 0.265 | ppl 1.2 | wps 17096.8 | ups 4.45 | wpb 3838.4 | bsz 290.1 | num_updates 5502 | lr 6.82118e-06 | gnorm 0.61 | loss_scale 2 | train_wall 62 | wall 1353
2021-01-19 05:26:22 | INFO | fairseq_cli.train | begin training epoch 17
2021-01-19 05:26:41 | INFO | train_inner | epoch 018:     98 / 324 loss=2.107, nll_loss=0.251, ppl=1.19, wps=13171.4, ups=3.39, wpb=3882.4, bsz=294.2, num_updates=5600, lr=6.76123e-06, gnorm=0.545, loss_scale=2, train_wall=19, wall=1372
2021-01-19 05:27:00 | INFO | train_inner | epoch 018:    198 / 324 loss=2.106, nll_loss=0.25, ppl=1.19, wps=19850.6, ups=5.17, wpb=3838.8, bsz=293.6, num_updates=5700, lr=6.70166e-06, gnorm=0.555, loss_scale=2, train_wall=19, wall=1391
2021-01-19 05:27:19 | INFO | train_inner | epoch 018:    298 / 324 loss=2.128, nll_loss=0.274, ppl=1.21, wps=19709.5, ups=5.18, wpb=3805.5, bsz=285.8, num_updates=5800, lr=6.64364e-06, gnorm=0.66, loss_scale=2, train_wall=19, wall=1411
2021-01-19 05:27:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:27:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:27:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:27:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:27:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:27:27 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:27:27 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:27:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (one trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:27:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:27:29 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 3.797 | nll_loss 2.081 | ppl 4.23 | bleu 42.56 | wps 920.3 | wpb 1083 | bsz 37.8 | num_updates 5826 | best_loss 3.624
2021-01-19 05:27:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:27:35 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 18 @ 5826 updates, score 3.797) (writing took 5.9502167487517 seconds)
2021-01-19 05:27:35 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-01-19 05:27:35 | INFO | train | epoch 018 | loss 2.114 | nll_loss 0.258 | ppl 1.2 | wps 16980.2 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 5826 | lr 6.6288e-06 | gnorm 0.582 | loss_scale 2 | train_wall 62 | wall 1426
2021-01-19 05:27:35 | INFO | fairseq_cli.train | begin training epoch 18
2021-01-19 05:27:49 | INFO | train_inner | epoch 019:     74 / 324 loss=2.112, nll_loss=0.255, ppl=1.19, wps=12671.1, ups=3.35, wpb=3778.7, bsz=281.6, num_updates=5900, lr=6.5871e-06, gnorm=0.576, loss_scale=2, train_wall=19, wall=1441
2021-01-19 05:28:09 | INFO | train_inner | epoch 019:    174 / 324 loss=2.102, nll_loss=0.246, ppl=1.19, wps=20009.4, ups=5.16, wpb=3879.5, bsz=297.2, num_updates=6000, lr=6.53197e-06, gnorm=0.546, loss_scale=2, train_wall=19, wall=1460
2021-01-19 05:28:28 | INFO | train_inner | epoch 019:    274 / 324 loss=2.107, nll_loss=0.252, ppl=1.19, wps=19937, ups=5.17, wpb=3856.8, bsz=294.8, num_updates=6100, lr=6.47821e-06, gnorm=0.58, loss_scale=2, train_wall=19, wall=1479
2021-01-19 05:28:38 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:28:38 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:28:38 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:28:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:28:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:28:40 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:28:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:28:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:28:42 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:28:42 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 3.825 | nll_loss 2.115 | ppl 4.33 | bleu 42.68 | wps 930 | wpb 1083 | bsz 37.8 | num_updates 6150 | best_loss 3.624
2021-01-19 05:28:42 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:28:48 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 19 @ 6150 updates, score 3.825) (writing took 5.4317135056480765 seconds)
2021-01-19 05:28:48 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-01-19 05:28:48 | INFO | train | epoch 019 | loss 2.108 | nll_loss 0.252 | ppl 1.19 | wps 17123.5 | ups 4.46 | wpb 3838.4 | bsz 290.1 | num_updates 6150 | lr 6.45182e-06 | gnorm 0.574 | loss_scale 2 | train_wall 62 | wall 1499
2021-01-19 05:28:48 | INFO | fairseq_cli.train | begin training epoch 19
2021-01-19 05:28:57 | INFO | train_inner | epoch 020:     50 / 324 loss=2.105, nll_loss=0.248, ppl=1.19, wps=13118, ups=3.4, wpb=3854.9, bsz=280.3, num_updates=6200, lr=6.42575e-06, gnorm=0.537, loss_scale=2, train_wall=19, wall=1509
2021-01-19 05:29:17 | INFO | train_inner | epoch 020:    150 / 324 loss=2.102, nll_loss=0.246, ppl=1.19, wps=19971, ups=5.17, wpb=3865.9, bsz=295.7, num_updates=6300, lr=6.37455e-06, gnorm=0.539, loss_scale=2, train_wall=19, wall=1528
2021-01-19 05:29:36 | INFO | train_inner | epoch 020:    250 / 324 loss=2.102, nll_loss=0.246, ppl=1.19, wps=19782.1, ups=5.17, wpb=3824.3, bsz=294.2, num_updates=6400, lr=6.32456e-06, gnorm=0.544, loss_scale=2, train_wall=19, wall=1547
2021-01-19 05:29:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:29:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:29:51 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:29:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:29:52 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:29:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-01-19 05:29:53 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:29:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (one trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c concentrations remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:29:55 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:29:55 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 3.838 | nll_loss 2.131 | ppl 4.38 | bleu 42.1 | wps 875.1 | wpb 1083 | bsz 37.8 | num_updates 6474 | best_loss 3.624
2021-01-19 05:29:55 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:30:01 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 20 @ 6474 updates, score 3.838) (writing took 6.251309410203248 seconds)
2021-01-19 05:30:01 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-01-19 05:30:01 | INFO | train | epoch 020 | loss 2.103 | nll_loss 0.247 | ppl 1.19 | wps 16879.3 | ups 4.4 | wpb 3838.4 | bsz 290.1 | num_updates 6474 | lr 6.28831e-06 | gnorm 0.546 | loss_scale 2 | train_wall 62 | wall 1573
2021-01-19 05:30:01 | INFO | fairseq_cli.train | begin training epoch 20
2021-01-19 05:30:06 | INFO | train_inner | epoch 021:     26 / 324 loss=2.106, nll_loss=0.249, ppl=1.19, wps=12519.1, ups=3.3, wpb=3788.4, bsz=280.6, num_updates=6500, lr=6.27572e-06, gnorm=0.566, loss_scale=2, train_wall=19, wall=1578
2021-01-19 05:30:26 | INFO | train_inner | epoch 021:    126 / 324 loss=2.115, nll_loss=0.26, ppl=1.2, wps=19730.7, ups=5.18, wpb=3807.8, bsz=281.4, num_updates=6600, lr=6.22799e-06, gnorm=0.604, loss_scale=2, train_wall=19, wall=1597
2021-01-19 05:30:45 | INFO | train_inner | epoch 021:    226 / 324 loss=2.092, nll_loss=0.236, ppl=1.18, wps=19997.9, ups=5.16, wpb=3877.1, bsz=298.4, num_updates=6700, lr=6.18134e-06, gnorm=0.513, loss_scale=2, train_wall=19, wall=1616
2021-01-19 05:31:04 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:31:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:31:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:31:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:31:05 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:31:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:31:06 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:31:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a study with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:31:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:31:09 | INFO | valid | epoch 021 | valid on 'valid' subset | loss 3.882 | nll_loss 2.179 | ppl 4.53 | bleu 42.41 | wps 903.8 | wpb 1083 | bsz 37.8 | num_updates 6798 | best_loss 3.624
2021-01-19 05:31:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:31:19 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 21 @ 6798 updates, score 3.882) (writing took 10.627195246051997 seconds)
2021-01-19 05:31:19 | INFO | fairseq_cli.train | end of epoch 21 (average epoch stats below)
2021-01-19 05:31:19 | INFO | train | epoch 021 | loss 2.098 | nll_loss 0.242 | ppl 1.18 | wps 15944.9 | ups 4.15 | wpb 3838.4 | bsz 290.1 | num_updates 6798 | lr 6.13662e-06 | gnorm 0.534 | loss_scale 2 | train_wall 62 | wall 1651
2021-01-19 05:31:19 | INFO | fairseq_cli.train | begin training epoch 21
2021-01-19 05:31:20 | INFO | train_inner | epoch 022:      2 / 324 loss=2.089, nll_loss=0.232, ppl=1.17, wps=11075.3, ups=2.88, wpb=3842.9, bsz=292.5, num_updates=6800, lr=6.13572e-06, gnorm=0.49, loss_scale=2, train_wall=19, wall=1651
2021-01-19 05:31:39 | INFO | train_inner | epoch 022:    102 / 324 loss=2.107, nll_loss=0.251, ppl=1.19, wps=19653.8, ups=5.18, wpb=3791.4, bsz=283.9, num_updates=6900, lr=6.0911e-06, gnorm=0.574, loss_scale=2, train_wall=19, wall=1670
2021-01-19 05:31:58 | INFO | train_inner | epoch 022:    202 / 324 loss=2.094, nll_loss=0.237, ppl=1.18, wps=19823.6, ups=5.18, wpb=3826.5, bsz=288.2, num_updates=7000, lr=6.04743e-06, gnorm=0.53, loss_scale=2, train_wall=19, wall=1690
2021-01-19 05:32:18 | INFO | train_inner | epoch 022:    302 / 324 loss=2.085, nll_loss=0.227, ppl=1.17, wps=19950.4, ups=5.15, wpb=3874.8, bsz=292.8, num_updates=7100, lr=6.00469e-06, gnorm=0.474, loss_scale=2, train_wall=19, wall=1709
2021-01-19 05:32:22 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:32:23 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:32:23 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:32:23 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-01-19 05:32:23 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:32:24 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:32:24 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:32:27 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:32:27 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:32:27 | INFO | valid | epoch 022 | valid on 'valid' subset | loss 3.894 | nll_loss 2.196 | ppl 4.58 | bleu 42.71 | wps 881.4 | wpb 1083 | bsz 37.8 | num_updates 7122 | best_loss 3.624
2021-01-19 05:32:27 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:32:33 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 22 @ 7122 updates, score 3.894) (writing took 5.795063073281199 seconds)
2021-01-19 05:32:33 | INFO | fairseq_cli.train | end of epoch 22 (average epoch stats below)
2021-01-19 05:32:33 | INFO | train | epoch 022 | loss 2.095 | nll_loss 0.238 | ppl 1.18 | wps 16956.4 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 7122 | lr 5.99541e-06 | gnorm 0.521 | loss_scale 2 | train_wall 62 | wall 1724
2021-01-19 05:32:33 | INFO | fairseq_cli.train | begin training epoch 22
2021-01-19 05:32:48 | INFO | train_inner | epoch 023:     78 / 324 loss=2.097, nll_loss=0.242, ppl=1.18, wps=12857.7, ups=3.34, wpb=3852.4, bsz=297.9, num_updates=7200, lr=5.96285e-06, gnorm=0.552, loss_scale=2, train_wall=19, wall=1739
2021-01-19 05:33:07 | INFO | train_inner | epoch 023:    178 / 324 loss=2.088, nll_loss=0.23, ppl=1.17, wps=19840.9, ups=5.18, wpb=3832.6, bsz=285.7, num_updates=7300, lr=5.92187e-06, gnorm=0.501, loss_scale=2, train_wall=19, wall=1758
2021-01-19 05:33:26 | INFO | train_inner | epoch 023:    278 / 324 loss=2.084, nll_loss=0.227, ppl=1.17, wps=19832.5, ups=5.16, wpb=3842.6, bsz=293.6, num_updates=7400, lr=5.88172e-06, gnorm=0.467, loss_scale=2, train_wall=19, wall=1778
2021-01-19 05:33:35 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:33:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:33:36 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:33:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:33:36 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:33:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:33:37 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:33:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c concentrations remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:33:40 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:33:40 | INFO | valid | epoch 023 | valid on 'valid' subset | loss 3.895 | nll_loss 2.2 | ppl 4.59 | bleu 42.32 | wps 905.7 | wpb 1083 | bsz 37.8 | num_updates 7446 | best_loss 3.624
2021-01-19 05:33:40 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:33:46 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 23 @ 7446 updates, score 3.895) (writing took 5.9974658619612455 seconds)
2021-01-19 05:33:46 | INFO | fairseq_cli.train | end of epoch 23 (average epoch stats below)
2021-01-19 05:33:46 | INFO | train | epoch 023 | loss 2.092 | nll_loss 0.235 | ppl 1.18 | wps 16977.6 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 7446 | lr 5.86352e-06 | gnorm 0.517 | loss_scale 2 | train_wall 62 | wall 1797
2021-01-19 05:33:46 | INFO | fairseq_cli.train | begin training epoch 23
2021-01-19 05:33:56 | INFO | train_inner | epoch 024:     54 / 324 loss=2.097, nll_loss=0.241, ppl=1.18, wps=12854.3, ups=3.34, wpb=3849.7, bsz=289.4, num_updates=7500, lr=5.84237e-06, gnorm=0.531, loss_scale=2, train_wall=19, wall=1808
2021-01-19 05:34:16 | INFO | train_inner | epoch 024:    154 / 324 loss=2.094, nll_loss=0.237, ppl=1.18, wps=19885.3, ups=5.17, wpb=3845.3, bsz=289, num_updates=7600, lr=5.80381e-06, gnorm=0.532, loss_scale=2, train_wall=19, wall=1827
2021-01-19 05:34:35 | INFO | train_inner | epoch 024:    254 / 324 loss=2.083, nll_loss=0.226, ppl=1.17, wps=19800.7, ups=5.18, wpb=3820.8, bsz=292.4, num_updates=7700, lr=5.766e-06, gnorm=0.488, loss_scale=2, train_wall=19, wall=1846
2021-01-19 05:34:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:34:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:34:49 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:34:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:34:50 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:34:51 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms called acute painful neuropathy, which are usually reversible.
2021-01-19 05:34:51 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:34:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP HbA1c concentrations remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:34:53 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:34:53 | INFO | valid | epoch 024 | valid on 'valid' subset | loss 3.917 | nll_loss 2.229 | ppl 4.69 | bleu 42.12 | wps 896.8 | wpb 1083 | bsz 37.8 | num_updates 7770 | best_loss 3.624
2021-01-19 05:34:53 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:34:59 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 24 @ 7770 updates, score 3.917) (writing took 5.709801486693323 seconds)
2021-01-19 05:34:59 | INFO | fairseq_cli.train | end of epoch 24 (average epoch stats below)
2021-01-19 05:34:59 | INFO | train | epoch 024 | loss 2.089 | nll_loss 0.232 | ppl 1.17 | wps 17024 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 7770 | lr 5.73997e-06 | gnorm 0.503 | loss_scale 2 | train_wall 62 | wall 1870
2021-01-19 05:34:59 | INFO | fairseq_cli.train | begin training epoch 24
2021-01-19 05:35:05 | INFO | train_inner | epoch 025:     30 / 324 loss=2.081, nll_loss=0.223, ppl=1.17, wps=12943.4, ups=3.35, wpb=3868.9, bsz=285.4, num_updates=7800, lr=5.72892e-06, gnorm=0.453, loss_scale=2, train_wall=19, wall=1876
2021-01-19 05:35:24 | INFO | train_inner | epoch 025:    130 / 324 loss=2.093, nll_loss=0.236, ppl=1.18, wps=19880, ups=5.17, wpb=3848.3, bsz=290.5, num_updates=7900, lr=5.69254e-06, gnorm=0.535, loss_scale=2, train_wall=19, wall=1896
2021-01-19 05:35:44 | INFO | train_inner | epoch 025:    230 / 324 loss=2.075, nll_loss=0.218, ppl=1.16, wps=19798.4, ups=5.15, wpb=3846.8, bsz=294.8, num_updates=8000, lr=5.65685e-06, gnorm=0.432, loss_scale=2, train_wall=19, wall=1915
2021-01-19 05:36:02 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:36:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:36:02 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:36:03 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:36:03 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:36:04 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:36:04 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:36:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:36:06 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:36:06 | INFO | valid | epoch 025 | valid on 'valid' subset | loss 3.922 | nll_loss 2.233 | ppl 4.7 | bleu 42.47 | wps 979.3 | wpb 1083 | bsz 37.8 | num_updates 8094 | best_loss 3.624
2021-01-19 05:36:06 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:36:12 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 25 @ 8094 updates, score 3.922) (writing took 5.648781264666468 seconds)
2021-01-19 05:36:12 | INFO | fairseq_cli.train | end of epoch 25 (average epoch stats below)
2021-01-19 05:36:12 | INFO | train | epoch 025 | loss 2.086 | nll_loss 0.229 | ppl 1.17 | wps 17088.2 | ups 4.45 | wpb 3838.4 | bsz 290.1 | num_updates 8094 | lr 5.62391e-06 | gnorm 0.496 | loss_scale 2 | train_wall 62 | wall 1943
2021-01-19 05:36:12 | INFO | fairseq_cli.train | begin training epoch 25
2021-01-19 05:36:13 | INFO | train_inner | epoch 026:      6 / 324 loss=2.095, nll_loss=0.24, ppl=1.18, wps=12980.2, ups=3.42, wpb=3796.2, bsz=288.8, num_updates=8100, lr=5.62183e-06, gnorm=0.574, loss_scale=2, train_wall=19, wall=1944
2021-01-19 05:36:32 | INFO | train_inner | epoch 026:    106 / 324 loss=2.076, nll_loss=0.217, ppl=1.16, wps=19781.4, ups=5.18, wpb=3816.4, bsz=285, num_updates=8200, lr=5.58744e-06, gnorm=0.45, loss_scale=2, train_wall=19, wall=1963
2021-01-19 05:36:52 | INFO | train_inner | epoch 026:    206 / 324 loss=2.084, nll_loss=0.227, ppl=1.17, wps=19967.8, ups=5.16, wpb=3873.3, bsz=293.7, num_updates=8300, lr=5.55368e-06, gnorm=0.484, loss_scale=2, train_wall=19, wall=1983
2021-01-19 05:37:11 | INFO | train_inner | epoch 026:    306 / 324 loss=2.091, nll_loss=0.235, ppl=1.18, wps=19753.6, ups=5.19, wpb=3808.3, bsz=286.6, num_updates=8400, lr=5.52052e-06, gnorm=0.516, loss_scale=2, train_wall=19, wall=2002
2021-01-19 05:37:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:37:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:37:15 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:37:16 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:37:16 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:37:17 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:37:17 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:37:19 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:37:19 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:37:19 | INFO | valid | epoch 026 | valid on 'valid' subset | loss 3.952 | nll_loss 2.271 | ppl 4.83 | bleu 42.41 | wps 928.6 | wpb 1083 | bsz 37.8 | num_updates 8418 | best_loss 3.624
2021-01-19 05:37:19 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:37:25 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 26 @ 8418 updates, score 3.952) (writing took 5.83421821705997 seconds)
2021-01-19 05:37:25 | INFO | fairseq_cli.train | end of epoch 26 (average epoch stats below)
2021-01-19 05:37:25 | INFO | train | epoch 026 | loss 2.083 | nll_loss 0.226 | ppl 1.17 | wps 17024.7 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 8418 | lr 5.51462e-06 | gnorm 0.484 | loss_scale 2 | train_wall 62 | wall 2016
2021-01-19 05:37:25 | INFO | fairseq_cli.train | begin training epoch 26
2021-01-19 05:37:41 | INFO | train_inner | epoch 027:     82 / 324 loss=2.082, nll_loss=0.226, ppl=1.17, wps=12966.1, ups=3.36, wpb=3857.9, bsz=293, num_updates=8500, lr=5.48795e-06, gnorm=0.479, loss_scale=2, train_wall=19, wall=2032
2021-01-19 05:38:00 | INFO | train_inner | epoch 027:    182 / 324 loss=2.084, nll_loss=0.227, ppl=1.17, wps=20010.6, ups=5.16, wpb=3881.6, bsz=294.3, num_updates=8600, lr=5.45595e-06, gnorm=0.482, loss_scale=2, train_wall=19, wall=2051
2021-01-19 05:38:19 | INFO | train_inner | epoch 027:    282 / 324 loss=2.075, nll_loss=0.217, ppl=1.16, wps=19782.2, ups=5.16, wpb=3830.3, bsz=293, num_updates=8700, lr=5.42451e-06, gnorm=0.451, loss_scale=2, train_wall=19, wall=2071
2021-01-19 05:38:27 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:38:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:38:28 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:38:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:38:29 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:38:30 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:38:30 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:38:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:38:32 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:38:32 | INFO | valid | epoch 027 | valid on 'valid' subset | loss 3.966 | nll_loss 2.287 | ppl 4.88 | bleu 43.12 | wps 866.7 | wpb 1083 | bsz 37.8 | num_updates 8742 | best_loss 3.624
2021-01-19 05:38:32 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:38:38 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 27 @ 8742 updates, score 3.966) (writing took 6.16667976975441 seconds)
2021-01-19 05:38:38 | INFO | fairseq_cli.train | end of epoch 27 (average epoch stats below)
2021-01-19 05:38:38 | INFO | train | epoch 027 | loss 2.081 | nll_loss 0.224 | ppl 1.17 | wps 16885.4 | ups 4.4 | wpb 3838.4 | bsz 290.1 | num_updates 8742 | lr 5.41146e-06 | gnorm 0.474 | loss_scale 2 | train_wall 62 | wall 2090
2021-01-19 05:38:38 | INFO | fairseq_cli.train | begin training epoch 27
2021-01-19 05:38:50 | INFO | train_inner | epoch 028:     58 / 324 loss=2.074, nll_loss=0.215, ppl=1.16, wps=12486.1, ups=3.3, wpb=3778.6, bsz=281.7, num_updates=8800, lr=5.3936e-06, gnorm=0.443, loss_scale=2, train_wall=19, wall=2101
2021-01-19 05:39:09 | INFO | train_inner | epoch 028:    158 / 324 loss=2.079, nll_loss=0.221, ppl=1.17, wps=19934.9, ups=5.17, wpb=3853.6, bsz=288.8, num_updates=8900, lr=5.36321e-06, gnorm=0.468, loss_scale=2, train_wall=19, wall=2120
2021-01-19 05:39:28 | INFO | train_inner | epoch 028:    258 / 324 loss=2.092, nll_loss=0.235, ppl=1.18, wps=19841.3, ups=5.17, wpb=3840.5, bsz=289.8, num_updates=9000, lr=5.33333e-06, gnorm=0.55, loss_scale=2, train_wall=19, wall=2140
2021-01-19 05:39:41 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:39:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:39:42 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:39:42 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is a fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:39:42 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:39:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:39:43 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:39:46 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a study with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has UNKNOWNTOKENINHYP Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:39:46 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:39:46 | INFO | valid | epoch 028 | valid on 'valid' subset | loss 3.987 | nll_loss 2.313 | ppl 4.97 | bleu 42.79 | wps 884.6 | wpb 1083 | bsz 37.8 | num_updates 9066 | best_loss 3.624
2021-01-19 05:39:46 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:39:52 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 28 @ 9066 updates, score 3.987) (writing took 5.876701286062598 seconds)
2021-01-19 05:39:52 | INFO | fairseq_cli.train | end of epoch 28 (average epoch stats below)
2021-01-19 05:39:52 | INFO | train | epoch 028 | loss 2.079 | nll_loss 0.222 | ppl 1.17 | wps 16970.3 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 9066 | lr 5.31388e-06 | gnorm 0.472 | loss_scale 2 | train_wall 62 | wall 2163
2021-01-19 05:39:52 | INFO | fairseq_cli.train | begin training epoch 28
2021-01-19 05:39:58 | INFO | train_inner | epoch 029:     34 / 324 loss=2.076, nll_loss=0.219, ppl=1.16, wps=12935.3, ups=3.34, wpb=3874.8, bsz=296.7, num_updates=9100, lr=5.30395e-06, gnorm=0.452, loss_scale=2, train_wall=19, wall=2170
2021-01-19 05:40:18 | INFO | train_inner | epoch 029:    134 / 324 loss=2.074, nll_loss=0.217, ppl=1.16, wps=20024.8, ups=5.18, wpb=3866.9, bsz=294.9, num_updates=9200, lr=5.27504e-06, gnorm=0.453, loss_scale=2, train_wall=19, wall=2189
2021-01-19 05:40:37 | INFO | train_inner | epoch 029:    234 / 324 loss=2.074, nll_loss=0.216, ppl=1.16, wps=19752.6, ups=5.16, wpb=3830.9, bsz=287.8, num_updates=9300, lr=5.24661e-06, gnorm=0.456, loss_scale=2, train_wall=19, wall=2208
2021-01-19 05:40:54 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:40:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid contains metacresol, which can cause allergic reactions.
2021-01-19 05:40:55 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:40:56 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:40:56 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:40:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:40:57 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:40:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (Insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:40:59 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:40:59 | INFO | valid | epoch 029 | valid on 'valid' subset | loss 3.985 | nll_loss 2.312 | ppl 4.97 | bleu 42.3 | wps 924 | wpb 1083 | bsz 37.8 | num_updates 9390 | best_loss 3.624
2021-01-19 05:40:59 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:41:04 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 29 @ 9390 updates, score 3.985) (writing took 5.565424444153905 seconds)
2021-01-19 05:41:04 | INFO | fairseq_cli.train | end of epoch 29 (average epoch stats below)
2021-01-19 05:41:04 | INFO | train | epoch 029 | loss 2.077 | nll_loss 0.22 | ppl 1.16 | wps 17077.1 | ups 4.45 | wpb 3838.4 | bsz 290.1 | num_updates 9390 | lr 5.2214e-06 | gnorm 0.463 | loss_scale 2 | train_wall 62 | wall 2236
2021-01-19 05:41:04 | INFO | fairseq_cli.train | begin training epoch 29
2021-01-19 05:41:07 | INFO | train_inner | epoch 030:     10 / 324 loss=2.076, nll_loss=0.217, ppl=1.16, wps=12805.3, ups=3.39, wpb=3778.5, bsz=279.1, num_updates=9400, lr=5.21862e-06, gnorm=0.44, loss_scale=2, train_wall=19, wall=2238
2021-01-19 05:41:26 | INFO | train_inner | epoch 030:    110 / 324 loss=2.076, nll_loss=0.219, ppl=1.16, wps=19790, ups=5.18, wpb=3820.4, bsz=289.1, num_updates=9500, lr=5.19109e-06, gnorm=0.466, loss_scale=2, train_wall=19, wall=2257
2021-01-19 05:41:45 | INFO | train_inner | epoch 030:    210 / 324 loss=2.076, nll_loss=0.22, ppl=1.16, wps=20107, ups=5.17, wpb=3891.1, bsz=297.5, num_updates=9600, lr=5.16398e-06, gnorm=0.476, loss_scale=2, train_wall=19, wall=2276
2021-01-19 05:42:04 | INFO | train_inner | epoch 030:    310 / 324 loss=2.078, nll_loss=0.221, ppl=1.17, wps=19757.5, ups=5.2, wpb=3801, bsz=287.6, num_updates=9700, lr=5.13729e-06, gnorm=0.456, loss_scale=2, train_wall=19, wall=2296
2021-01-19 05:42:07 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:42:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:42:08 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:42:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:42:08 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:42:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:42:09 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:42:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:42:12 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:42:12 | INFO | valid | epoch 030 | valid on 'valid' subset | loss 4.015 | nll_loss 2.345 | ppl 5.08 | bleu 42.31 | wps 954.4 | wpb 1083 | bsz 37.8 | num_updates 9714 | best_loss 3.624
2021-01-19 05:42:12 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:42:17 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 30 @ 9714 updates, score 4.015) (writing took 5.471471356693655 seconds)
2021-01-19 05:42:17 | INFO | fairseq_cli.train | end of epoch 30 (average epoch stats below)
2021-01-19 05:42:17 | INFO | train | epoch 030 | loss 2.075 | nll_loss 0.218 | ppl 1.16 | wps 17151 | ups 4.47 | wpb 3838.4 | bsz 290.1 | num_updates 9714 | lr 5.13359e-06 | gnorm 0.458 | loss_scale 2 | train_wall 62 | wall 2308
2021-01-19 05:42:17 | INFO | fairseq_cli.train | begin training epoch 30
2021-01-19 05:42:34 | INFO | train_inner | epoch 031:     86 / 324 loss=2.064, nll_loss=0.205, ppl=1.15, wps=13131.1, ups=3.41, wpb=3851.1, bsz=291.3, num_updates=9800, lr=5.11101e-06, gnorm=0.39, loss_scale=2, train_wall=19, wall=2325
2021-01-19 05:42:53 | INFO | train_inner | epoch 031:    186 / 324 loss=2.078, nll_loss=0.221, ppl=1.17, wps=19861.5, ups=5.18, wpb=3833.5, bsz=288, num_updates=9900, lr=5.08513e-06, gnorm=0.479, loss_scale=2, train_wall=19, wall=2344
2021-01-19 05:43:12 | INFO | train_inner | epoch 031:    286 / 324 loss=2.075, nll_loss=0.218, ppl=1.16, wps=19865.7, ups=5.18, wpb=3832.3, bsz=288.6, num_updates=10000, lr=5.05964e-06, gnorm=0.457, loss_scale=2, train_wall=19, wall=2364
2021-01-19 05:43:20 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:43:20 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:43:20 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:43:21 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:43:21 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:43:22 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:43:22 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:43:24 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has UNKNOWNTOKENINHYP Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:43:24 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:43:24 | INFO | valid | epoch 031 | valid on 'valid' subset | loss 4.008 | nll_loss 2.34 | ppl 5.06 | bleu 42.46 | wps 921.4 | wpb 1083 | bsz 37.8 | num_updates 10038 | best_loss 3.624
2021-01-19 05:43:24 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:43:31 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 31 @ 10038 updates, score 4.008) (writing took 7.075227084103972 seconds)
2021-01-19 05:43:31 | INFO | fairseq_cli.train | end of epoch 31 (average epoch stats below)
2021-01-19 05:43:31 | INFO | train | epoch 031 | loss 2.073 | nll_loss 0.216 | ppl 1.16 | wps 16735 | ups 4.36 | wpb 3838.4 | bsz 290.1 | num_updates 10038 | lr 5.05006e-06 | gnorm 0.452 | loss_scale 2 | train_wall 62 | wall 2383
2021-01-19 05:43:31 | INFO | fairseq_cli.train | begin training epoch 31
2021-01-19 05:43:43 | INFO | train_inner | epoch 032:     62 / 324 loss=2.072, nll_loss=0.213, ppl=1.16, wps=12237, ups=3.23, wpb=3792.7, bsz=280.2, num_updates=10100, lr=5.03453e-06, gnorm=0.443, loss_scale=2, train_wall=19, wall=2395
2021-01-19 05:44:03 | INFO | train_inner | epoch 032:    162 / 324 loss=2.072, nll_loss=0.215, ppl=1.16, wps=19950.7, ups=5.18, wpb=3850.2, bsz=291.1, num_updates=10200, lr=5.00979e-06, gnorm=0.448, loss_scale=2, train_wall=19, wall=2414
2021-01-19 05:44:22 | INFO | train_inner | epoch 032:    262 / 324 loss=2.075, nll_loss=0.219, ppl=1.16, wps=20015.8, ups=5.15, wpb=3890.1, bsz=298.6, num_updates=10300, lr=4.98542e-06, gnorm=0.444, loss_scale=2, train_wall=19, wall=2433
2021-01-19 05:44:34 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:44:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:44:35 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:44:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:44:35 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:44:36 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:44:36 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:44:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:44:39 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:44:39 | INFO | valid | epoch 032 | valid on 'valid' subset | loss 4.028 | nll_loss 2.364 | ppl 5.15 | bleu 42.09 | wps 891 | wpb 1083 | bsz 37.8 | num_updates 10362 | best_loss 3.624
2021-01-19 05:44:39 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:44:45 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 32 @ 10362 updates, score 4.028) (writing took 5.931761362124234 seconds)
2021-01-19 05:44:45 | INFO | fairseq_cli.train | end of epoch 32 (average epoch stats below)
2021-01-19 05:44:45 | INFO | train | epoch 032 | loss 2.072 | nll_loss 0.215 | ppl 1.16 | wps 16954.7 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 10362 | lr 4.97048e-06 | gnorm 0.439 | loss_scale 2 | train_wall 62 | wall 2456
2021-01-19 05:44:45 | INFO | fairseq_cli.train | begin training epoch 32
2021-01-19 05:44:52 | INFO | train_inner | epoch 033:     38 / 324 loss=2.072, nll_loss=0.214, ppl=1.16, wps=12615.8, ups=3.34, wpb=3781.7, bsz=287.4, num_updates=10400, lr=4.96139e-06, gnorm=0.457, loss_scale=2, train_wall=19, wall=2463
2021-01-19 05:45:11 | INFO | train_inner | epoch 033:    138 / 324 loss=2.079, nll_loss=0.223, ppl=1.17, wps=20178, ups=5.18, wpb=3892.5, bsz=297.8, num_updates=10500, lr=4.93771e-06, gnorm=0.478, loss_scale=2, train_wall=19, wall=2483
2021-01-19 05:45:31 | INFO | train_inner | epoch 033:    238 / 324 loss=2.068, nll_loss=0.21, ppl=1.16, wps=19734.9, ups=5.18, wpb=3809.2, bsz=288.3, num_updates=10600, lr=4.91436e-06, gnorm=0.432, loss_scale=2, train_wall=19, wall=2502
2021-01-19 05:45:47 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:45:48 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:45:48 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:45:49 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:45:49 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:45:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which is usually reversible.
2021-01-19 05:45:50 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:45:52 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes in which the body is unable to process insulin effectively (a study with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has UNKNOWNTOKENINHYP Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:45:52 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:45:52 | INFO | valid | epoch 033 | valid on 'valid' subset | loss 4.03 | nll_loss 2.368 | ppl 5.16 | bleu 42.08 | wps 963.4 | wpb 1083 | bsz 37.8 | num_updates 10686 | best_loss 3.624
2021-01-19 05:45:52 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:45:58 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 33 @ 10686 updates, score 4.03) (writing took 5.807103476952761 seconds)
2021-01-19 05:45:58 | INFO | fairseq_cli.train | end of epoch 33 (average epoch stats below)
2021-01-19 05:45:58 | INFO | train | epoch 033 | loss 2.071 | nll_loss 0.214 | ppl 1.16 | wps 17061.1 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 10686 | lr 4.89455e-06 | gnorm 0.44 | loss_scale 2 | train_wall 62 | wall 2529
2021-01-19 05:45:58 | INFO | fairseq_cli.train | begin training epoch 33
2021-01-19 05:46:00 | INFO | train_inner | epoch 034:     14 / 324 loss=2.067, nll_loss=0.209, ppl=1.16, wps=12988.1, ups=3.37, wpb=3854.4, bsz=288.8, num_updates=10700, lr=4.89134e-06, gnorm=0.409, loss_scale=2, train_wall=19, wall=2532
2021-01-19 05:46:20 | INFO | train_inner | epoch 034:    114 / 324 loss=2.073, nll_loss=0.216, ppl=1.16, wps=19759.6, ups=5.18, wpb=3817.1, bsz=287.4, num_updates=10800, lr=4.86864e-06, gnorm=0.479, loss_scale=2, train_wall=19, wall=2551
2021-01-19 05:46:39 | INFO | train_inner | epoch 034:    214 / 324 loss=2.064, nll_loss=0.206, ppl=1.15, wps=19924.7, ups=5.17, wpb=3853.9, bsz=293, num_updates=10900, lr=4.84626e-06, gnorm=0.394, loss_scale=2, train_wall=19, wall=2570
2021-01-19 05:46:58 | INFO | train_inner | epoch 034:    314 / 324 loss=2.07, nll_loss=0.212, ppl=1.16, wps=19859.3, ups=5.18, wpb=3834.2, bsz=291.7, num_updates=11000, lr=4.82418e-06, gnorm=0.427, loss_scale=2, train_wall=19, wall=2590
2021-01-19 05:47:00 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:47:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:47:01 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:47:01 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:47:01 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:47:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:47:02 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:47:05 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:47:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:47:05 | INFO | valid | epoch 034 | valid on 'valid' subset | loss 4.045 | nll_loss 2.386 | ppl 5.23 | bleu 42.46 | wps 909.2 | wpb 1083 | bsz 37.8 | num_updates 11010 | best_loss 3.624
2021-01-19 05:47:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:47:10 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 34 @ 11010 updates, score 4.045) (writing took 5.456025135703385 seconds)
2021-01-19 05:47:10 | INFO | fairseq_cli.train | end of epoch 34 (average epoch stats below)
2021-01-19 05:47:10 | INFO | train | epoch 034 | loss 2.07 | nll_loss 0.212 | ppl 1.16 | wps 17102.5 | ups 4.46 | wpb 3838.4 | bsz 290.1 | num_updates 11010 | lr 4.82199e-06 | gnorm 0.437 | loss_scale 2 | train_wall 62 | wall 2602
2021-01-19 05:47:10 | INFO | fairseq_cli.train | begin training epoch 34
2021-01-19 05:47:28 | INFO | train_inner | epoch 035:     90 / 324 loss=2.065, nll_loss=0.208, ppl=1.16, wps=13106.4, ups=3.39, wpb=3864.9, bsz=294.2, num_updates=11100, lr=4.8024e-06, gnorm=0.421, loss_scale=2, train_wall=19, wall=2619
2021-01-19 05:47:47 | INFO | train_inner | epoch 035:    190 / 324 loss=2.076, nll_loss=0.219, ppl=1.16, wps=19915.2, ups=5.18, wpb=3845.8, bsz=289.7, num_updates=11200, lr=4.78091e-06, gnorm=0.471, loss_scale=2, train_wall=19, wall=2638
2021-01-19 05:48:06 | INFO | train_inner | epoch 035:    290 / 324 loss=2.065, nll_loss=0.207, ppl=1.15, wps=19774.2, ups=5.19, wpb=3812.5, bsz=289.2, num_updates=11300, lr=4.75971e-06, gnorm=0.419, loss_scale=2, train_wall=19, wall=2658
2021-01-19 05:48:13 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:48:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:48:14 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:48:14 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:48:14 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:48:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:48:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:48:18 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapid was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:48:18 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:48:18 | INFO | valid | epoch 035 | valid on 'valid' subset | loss 4.038 | nll_loss 2.38 | ppl 5.21 | bleu 42.51 | wps 895 | wpb 1083 | bsz 37.8 | num_updates 11334 | best_loss 3.624
2021-01-19 05:48:18 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:48:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 35 @ 11334 updates, score 4.038) (writing took 5.428632082883269 seconds)
2021-01-19 05:48:23 | INFO | fairseq_cli.train | end of epoch 35 (average epoch stats below)
2021-01-19 05:48:23 | INFO | train | epoch 035 | loss 2.069 | nll_loss 0.211 | ppl 1.16 | wps 17089.7 | ups 4.45 | wpb 3838.4 | bsz 290.1 | num_updates 11334 | lr 4.75257e-06 | gnorm 0.439 | loss_scale 2 | train_wall 62 | wall 2674
2021-01-19 05:48:23 | INFO | fairseq_cli.train | begin training epoch 35
2021-01-19 05:48:36 | INFO | train_inner | epoch 036:     66 / 324 loss=2.063, nll_loss=0.204, ppl=1.15, wps=13117.4, ups=3.37, wpb=3886.8, bsz=289.4, num_updates=11400, lr=4.73879e-06, gnorm=0.392, loss_scale=2, train_wall=19, wall=2687
2021-01-19 05:48:55 | INFO | train_inner | epoch 036:    166 / 324 loss=2.071, nll_loss=0.214, ppl=1.16, wps=19670, ups=5.18, wpb=3798.1, bsz=280.3, num_updates=11500, lr=4.71814e-06, gnorm=0.451, loss_scale=2, train_wall=19, wall=2707
2021-01-19 05:49:15 | INFO | train_inner | epoch 036:    266 / 324 loss=2.072, nll_loss=0.216, ppl=1.16, wps=19741.8, ups=5.16, wpb=3823.1, bsz=294, num_updates=11600, lr=4.69776e-06, gnorm=0.453, loss_scale=2, train_wall=19, wall=2726
2021-01-19 05:49:26 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:49:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:49:26 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:49:27 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:49:27 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:49:28 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:49:28 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:49:31 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:49:31 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:49:31 | INFO | valid | epoch 036 | valid on 'valid' subset | loss 4.062 | nll_loss 2.408 | ppl 5.31 | bleu 42.75 | wps 902.6 | wpb 1083 | bsz 37.8 | num_updates 11658 | best_loss 3.624
2021-01-19 05:49:31 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:49:36 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 36 @ 11658 updates, score 4.062) (writing took 5.750066344626248 seconds)
2021-01-19 05:49:36 | INFO | fairseq_cli.train | end of epoch 36 (average epoch stats below)
2021-01-19 05:49:36 | INFO | train | epoch 036 | loss 2.067 | nll_loss 0.21 | ppl 1.16 | wps 16983.5 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 11658 | lr 4.68606e-06 | gnorm 0.422 | loss_scale 2 | train_wall 62 | wall 2748
2021-01-19 05:49:36 | INFO | fairseq_cli.train | begin training epoch 36
2021-01-19 05:49:45 | INFO | train_inner | epoch 037:     42 / 324 loss=2.063, nll_loss=0.205, ppl=1.15, wps=13002.5, ups=3.35, wpb=3880.2, bsz=292.8, num_updates=11700, lr=4.67764e-06, gnorm=0.39, loss_scale=2, train_wall=19, wall=2756
2021-01-19 05:50:04 | INFO | train_inner | epoch 037:    142 / 324 loss=2.065, nll_loss=0.207, ppl=1.15, wps=19734.1, ups=5.19, wpb=3805.2, bsz=285.4, num_updates=11800, lr=4.65778e-06, gnorm=0.419, loss_scale=2, train_wall=19, wall=2775
2021-01-19 05:50:23 | INFO | train_inner | epoch 037:    242 / 324 loss=2.062, nll_loss=0.205, ppl=1.15, wps=19815.9, ups=5.15, wpb=3845, bsz=295, num_updates=11900, lr=4.63817e-06, gnorm=0.399, loss_scale=2, train_wall=19, wall=2794
2021-01-19 05:50:39 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:50:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which can cause allergic reactions.
2021-01-19 05:50:40 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:50:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:50:40 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:50:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:50:41 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:50:44 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:50:44 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:50:44 | INFO | valid | epoch 037 | valid on 'valid' subset | loss 4.08 | nll_loss 2.429 | ppl 5.39 | bleu 42.29 | wps 888.4 | wpb 1083 | bsz 37.8 | num_updates 11982 | best_loss 3.624
2021-01-19 05:50:44 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:50:49 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 37 @ 11982 updates, score 4.08) (writing took 5.667724186554551 seconds)
2021-01-19 05:50:49 | INFO | fairseq_cli.train | end of epoch 37 (average epoch stats below)
2021-01-19 05:50:49 | INFO | train | epoch 037 | loss 2.066 | nll_loss 0.209 | ppl 1.16 | wps 16996.9 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 11982 | lr 4.62227e-06 | gnorm 0.423 | loss_scale 2 | train_wall 62 | wall 2821
2021-01-19 05:50:49 | INFO | fairseq_cli.train | begin training epoch 37
2021-01-19 05:50:53 | INFO | train_inner | epoch 038:     18 / 324 loss=2.07, nll_loss=0.213, ppl=1.16, wps=12907.8, ups=3.35, wpb=3848.9, bsz=291.7, num_updates=12000, lr=4.6188e-06, gnorm=0.451, loss_scale=2, train_wall=19, wall=2824
2021-01-19 05:51:12 | INFO | train_inner | epoch 038:    118 / 324 loss=2.059, nll_loss=0.201, ppl=1.15, wps=19843.9, ups=5.17, wpb=3835.9, bsz=289.9, num_updates=12100, lr=4.59968e-06, gnorm=0.368, loss_scale=2, train_wall=19, wall=2844
2021-01-19 05:51:32 | INFO | train_inner | epoch 038:    218 / 324 loss=2.072, nll_loss=0.214, ppl=1.16, wps=19804.6, ups=5.19, wpb=3814.2, bsz=283.6, num_updates=12200, lr=4.58079e-06, gnorm=0.492, loss_scale=2, train_wall=19, wall=2863
2021-01-19 05:51:51 | INFO | train_inner | epoch 038:    318 / 324 loss=2.065, nll_loss=0.208, ppl=1.16, wps=19831.7, ups=5.16, wpb=3842.6, bsz=291.8, num_updates=12300, lr=4.56213e-06, gnorm=0.411, loss_scale=2, train_wall=19, wall=2882
2021-01-19 05:51:52 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:51:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 05:51:53 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:51:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:51:53 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:51:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms called acute painful neuropathy, which is usually reversible.
2021-01-19 05:51:54 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:51:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c), which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:51:57 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:51:57 | INFO | valid | epoch 038 | valid on 'valid' subset | loss 4.07 | nll_loss 2.418 | ppl 5.35 | bleu 42.76 | wps 913.9 | wpb 1083 | bsz 37.8 | num_updates 12306 | best_loss 3.624
2021-01-19 05:51:57 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:52:03 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 38 @ 12306 updates, score 4.07) (writing took 5.819200514815748 seconds)
2021-01-19 05:52:03 | INFO | fairseq_cli.train | end of epoch 38 (average epoch stats below)
2021-01-19 05:52:03 | INFO | train | epoch 038 | loss 2.065 | nll_loss 0.208 | ppl 1.16 | wps 17011.4 | ups 4.43 | wpb 3838.4 | bsz 290.1 | num_updates 12306 | lr 4.56102e-06 | gnorm 0.423 | loss_scale 2 | train_wall 62 | wall 2894
2021-01-19 05:52:03 | INFO | fairseq_cli.train | begin training epoch 38
2021-01-19 05:52:21 | INFO | train_inner | epoch 039:     94 / 324 loss=2.06, nll_loss=0.203, ppl=1.15, wps=12974.4, ups=3.35, wpb=3869, bsz=292.8, num_updates=12400, lr=4.54369e-06, gnorm=0.402, loss_scale=2, train_wall=19, wall=2912
2021-01-19 05:52:40 | INFO | train_inner | epoch 039:    194 / 324 loss=2.069, nll_loss=0.213, ppl=1.16, wps=19829.3, ups=5.19, wpb=3819.9, bsz=289.4, num_updates=12500, lr=4.52548e-06, gnorm=0.427, loss_scale=2, train_wall=19, wall=2931
2021-01-19 05:52:59 | INFO | train_inner | epoch 039:    294 / 324 loss=2.066, nll_loss=0.209, ppl=1.16, wps=19979.7, ups=5.16, wpb=3871, bsz=295.9, num_updates=12600, lr=4.50749e-06, gnorm=0.432, loss_scale=2, train_wall=19, wall=2951
2021-01-19 05:53:05 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:53:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 05:53:06 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:53:06 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:53:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:53:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:53:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:53:10 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6-month treatment with Actrapid.
2021-01-19 05:53:10 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:53:10 | INFO | valid | epoch 039 | valid on 'valid' subset | loss 4.096 | nll_loss 2.449 | ppl 5.46 | bleu 42.91 | wps 900.1 | wpb 1083 | bsz 37.8 | num_updates 12630 | best_loss 3.624
2021-01-19 05:53:10 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:53:15 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 39 @ 12630 updates, score 4.096) (writing took 5.644551193807274 seconds)
2021-01-19 05:53:15 | INFO | fairseq_cli.train | end of epoch 39 (average epoch stats below)
2021-01-19 05:53:15 | INFO | train | epoch 039 | loss 2.065 | nll_loss 0.207 | ppl 1.15 | wps 17059.4 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 12630 | lr 4.50213e-06 | gnorm 0.416 | loss_scale 2 | train_wall 62 | wall 2967
2021-01-19 05:53:15 | INFO | fairseq_cli.train | begin training epoch 39
2021-01-19 05:53:29 | INFO | train_inner | epoch 040:     70 / 324 loss=2.058, nll_loss=0.199, ppl=1.15, wps=12660.7, ups=3.39, wpb=3738.6, bsz=278.2, num_updates=12700, lr=4.48971e-06, gnorm=0.377, loss_scale=2, train_wall=19, wall=2980
2021-01-19 05:53:48 | INFO | train_inner | epoch 040:    170 / 324 loss=2.056, nll_loss=0.198, ppl=1.15, wps=19972.9, ups=5.15, wpb=3875.7, bsz=296.9, num_updates=12800, lr=4.47214e-06, gnorm=0.365, loss_scale=2, train_wall=19, wall=3000
2021-01-19 05:54:08 | INFO | train_inner | epoch 040:    270 / 324 loss=2.061, nll_loss=0.204, ppl=1.15, wps=19971.1, ups=5.13, wpb=3889.4, bsz=295.7, num_updates=12900, lr=4.45477e-06, gnorm=0.379, loss_scale=2, train_wall=19, wall=3019
2021-01-19 05:54:18 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:54:19 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 05:54:19 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:54:20 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:54:20 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:54:20 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:54:20 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:54:23 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) which indicates how well blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6-month treatment with Actrapid.
2021-01-19 05:54:23 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:54:23 | INFO | valid | epoch 040 | valid on 'valid' subset | loss 4.104 | nll_loss 2.461 | ppl 5.51 | bleu 42.44 | wps 952.4 | wpb 1083 | bsz 37.8 | num_updates 12954 | best_loss 3.624
2021-01-19 05:54:23 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:54:28 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 40 @ 12954 updates, score 4.104) (writing took 5.560739452019334 seconds)
2021-01-19 05:54:28 | INFO | fairseq_cli.train | end of epoch 40 (average epoch stats below)
2021-01-19 05:54:28 | INFO | train | epoch 040 | loss 2.063 | nll_loss 0.206 | ppl 1.15 | wps 17093.4 | ups 4.45 | wpb 3838.4 | bsz 290.1 | num_updates 12954 | lr 4.44547e-06 | gnorm 0.408 | loss_scale 2 | train_wall 62 | wall 3039
2021-01-19 05:54:28 | INFO | fairseq_cli.train | begin training epoch 40
2021-01-19 05:54:37 | INFO | train_inner | epoch 041:     46 / 324 loss=2.077, nll_loss=0.22, ppl=1.16, wps=12924.1, ups=3.41, wpb=3788.1, bsz=281.8, num_updates=13000, lr=4.4376e-06, gnorm=0.511, loss_scale=2, train_wall=19, wall=3048
2021-01-19 05:54:57 | INFO | train_inner | epoch 041:    146 / 324 loss=2.068, nll_loss=0.212, ppl=1.16, wps=19997.4, ups=5.13, wpb=3897.1, bsz=300.6, num_updates=13100, lr=4.42063e-06, gnorm=0.441, loss_scale=2, train_wall=19, wall=3068
2021-01-19 05:55:16 | INFO | train_inner | epoch 041:    246 / 324 loss=2.059, nll_loss=0.202, ppl=1.15, wps=19882.6, ups=5.14, wpb=3864.9, bsz=286.5, num_updates=13200, lr=4.40386e-06, gnorm=0.379, loss_scale=2, train_wall=19, wall=3087
2021-01-19 05:55:31 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:55:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 05:55:32 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:55:32 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:55:32 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:55:33 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:55:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:55:35 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:55:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:55:35 | INFO | valid | epoch 041 | valid on 'valid' subset | loss 4.114 | nll_loss 2.469 | ppl 5.54 | bleu 42.68 | wps 958.4 | wpb 1083 | bsz 37.8 | num_updates 13278 | best_loss 3.624
2021-01-19 05:55:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:55:42 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 41 @ 13278 updates, score 4.114) (writing took 6.6863532229326665 seconds)
2021-01-19 05:55:42 | INFO | fairseq_cli.train | end of epoch 41 (average epoch stats below)
2021-01-19 05:55:42 | INFO | train | epoch 041 | loss 2.063 | nll_loss 0.205 | ppl 1.15 | wps 16811.4 | ups 4.38 | wpb 3838.4 | bsz 290.1 | num_updates 13278 | lr 4.3909e-06 | gnorm 0.406 | loss_scale 2 | train_wall 62 | wall 3113
2021-01-19 05:55:42 | INFO | fairseq_cli.train | begin training epoch 41
2021-01-19 05:55:47 | INFO | train_inner | epoch 042:     22 / 324 loss=2.062, nll_loss=0.204, ppl=1.15, wps=12509.6, ups=3.28, wpb=3811.5, bsz=292.6, num_updates=13300, lr=4.38727e-06, gnorm=0.393, loss_scale=2, train_wall=19, wall=3118
2021-01-19 05:56:06 | INFO | train_inner | epoch 042:    122 / 324 loss=2.063, nll_loss=0.205, ppl=1.15, wps=19665, ups=5.17, wpb=3801.8, bsz=287.3, num_updates=13400, lr=4.37087e-06, gnorm=0.425, loss_scale=2, train_wall=19, wall=3137
2021-01-19 05:56:25 | INFO | train_inner | epoch 042:    222 / 324 loss=2.066, nll_loss=0.209, ppl=1.16, wps=19825.1, ups=5.18, wpb=3827.1, bsz=288.9, num_updates=13500, lr=4.35465e-06, gnorm=0.427, loss_scale=2, train_wall=19, wall=3156
2021-01-19 05:56:45 | INFO | train_inner | epoch 042:    322 / 324 loss=2.058, nll_loss=0.2, ppl=1.15, wps=19839.9, ups=5.14, wpb=3861.8, bsz=288.8, num_updates=13600, lr=4.33861e-06, gnorm=0.369, loss_scale=2, train_wall=19, wall=3176
2021-01-19 05:56:45 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:56:46 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 05:56:46 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:56:46 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:56:46 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:56:47 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:56:47 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:56:50 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c) which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit did UNKNOWNTOKENINHYP Actrapid show in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:56:50 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:56:50 | INFO | valid | epoch 042 | valid on 'valid' subset | loss 4.13 | nll_loss 2.49 | ppl 5.62 | bleu 42.7 | wps 907.4 | wpb 1083 | bsz 37.8 | num_updates 13602 | best_loss 3.624
2021-01-19 05:56:50 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:56:55 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 42 @ 13602 updates, score 4.13) (writing took 5.518213736824691 seconds)
2021-01-19 05:56:55 | INFO | fairseq_cli.train | end of epoch 42 (average epoch stats below)
2021-01-19 05:56:55 | INFO | train | epoch 042 | loss 2.062 | nll_loss 0.205 | ppl 1.15 | wps 17039.9 | ups 4.44 | wpb 3838.4 | bsz 290.1 | num_updates 13602 | lr 4.33829e-06 | gnorm 0.404 | loss_scale 2 | train_wall 62 | wall 3186
2021-01-19 05:56:55 | INFO | fairseq_cli.train | begin training epoch 42
2021-01-19 05:57:14 | INFO | train_inner | epoch 043:     98 / 324 loss=2.058, nll_loss=0.2, ppl=1.15, wps=12808.1, ups=3.39, wpb=3774.7, bsz=285, num_updates=13700, lr=4.32275e-06, gnorm=0.396, loss_scale=2, train_wall=19, wall=3205
2021-01-19 05:57:34 | INFO | train_inner | epoch 043:    198 / 324 loss=2.06, nll_loss=0.202, ppl=1.15, wps=19829.8, ups=5.16, wpb=3841.8, bsz=282.6, num_updates=13800, lr=4.30706e-06, gnorm=0.386, loss_scale=2, train_wall=19, wall=3225
2021-01-19 05:57:53 | INFO | train_inner | epoch 043:    298 / 324 loss=2.068, nll_loss=0.213, ppl=1.16, wps=20080.2, ups=5.17, wpb=3884.4, bsz=301.4, num_updates=13900, lr=4.29153e-06, gnorm=0.443, loss_scale=2, train_wall=19, wall=3244
2021-01-19 05:57:58 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:57:58 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 05:57:58 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:57:59 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:57:59 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:58:00 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:58:00 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:58:02 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a study of 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c) which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has UNKNOWNTOKENINHYP Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 05:58:02 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:58:02 | INFO | valid | epoch 043 | valid on 'valid' subset | loss 4.13 | nll_loss 2.492 | ppl 5.63 | bleu 42.82 | wps 965.6 | wpb 1083 | bsz 37.8 | num_updates 13926 | best_loss 3.624
2021-01-19 05:58:02 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:58:08 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 43 @ 13926 updates, score 4.13) (writing took 5.34903671592474 seconds)
2021-01-19 05:58:08 | INFO | fairseq_cli.train | end of epoch 43 (average epoch stats below)
2021-01-19 05:58:08 | INFO | train | epoch 043 | loss 2.061 | nll_loss 0.204 | ppl 1.15 | wps 17172.5 | ups 4.47 | wpb 3838.4 | bsz 290.1 | num_updates 13926 | lr 4.28753e-06 | gnorm 0.403 | loss_scale 2 | train_wall 62 | wall 3259
2021-01-19 05:58:08 | INFO | fairseq_cli.train | begin training epoch 43
2021-01-19 05:58:22 | INFO | train_inner | epoch 044:     74 / 324 loss=2.06, nll_loss=0.203, ppl=1.15, wps=13150.4, ups=3.44, wpb=3824.6, bsz=283.5, num_updates=14000, lr=4.27618e-06, gnorm=0.386, loss_scale=2, train_wall=19, wall=3273
2021-01-19 05:58:41 | INFO | train_inner | epoch 044:    174 / 324 loss=2.056, nll_loss=0.198, ppl=1.15, wps=19839, ups=5.15, wpb=3852.9, bsz=292.8, num_updates=14100, lr=4.26099e-06, gnorm=0.38, loss_scale=2, train_wall=19, wall=3293
2021-01-19 05:59:01 | INFO | train_inner | epoch 044:    274 / 324 loss=2.064, nll_loss=0.207, ppl=1.15, wps=19853.5, ups=5.18, wpb=3836.3, bsz=290.8, num_updates=14200, lr=4.24596e-06, gnorm=0.416, loss_scale=2, train_wall=19, wall=3312
2021-01-19 05:59:10 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 05:59:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 05:59:11 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 05:59:12 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 05:59:12 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 05:59:13 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 05:59:13 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 05:59:15 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a study of 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6-month treatment with Actrapid.
2021-01-19 05:59:15 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 05:59:15 | INFO | valid | epoch 044 | valid on 'valid' subset | loss 4.143 | nll_loss 2.508 | ppl 5.69 | bleu 43.09 | wps 903.9 | wpb 1083 | bsz 37.8 | num_updates 14250 | best_loss 3.624
2021-01-19 05:59:15 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 05:59:21 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 44 @ 14250 updates, score 4.143) (writing took 6.0915755880996585 seconds)
2021-01-19 05:59:21 | INFO | fairseq_cli.train | end of epoch 44 (average epoch stats below)
2021-01-19 05:59:21 | INFO | train | epoch 044 | loss 2.061 | nll_loss 0.204 | ppl 1.15 | wps 16916 | ups 4.41 | wpb 3838.4 | bsz 290.1 | num_updates 14250 | lr 4.2385e-06 | gnorm 0.4 | loss_scale 2 | train_wall 62 | wall 3332
2021-01-19 05:59:21 | INFO | fairseq_cli.train | begin training epoch 44
2021-01-19 05:59:31 | INFO | train_inner | epoch 045:     50 / 324 loss=2.06, nll_loss=0.204, ppl=1.15, wps=12758.4, ups=3.32, wpb=3844, bsz=300.2, num_updates=14300, lr=4.23109e-06, gnorm=0.394, loss_scale=2, train_wall=19, wall=3342
2021-01-19 05:59:50 | INFO | train_inner | epoch 045:    150 / 324 loss=2.051, nll_loss=0.192, ppl=1.14, wps=19618.2, ups=5.18, wpb=3790.2, bsz=278.8, num_updates=14400, lr=4.21637e-06, gnorm=0.343, loss_scale=2, train_wall=19, wall=3361
2021-01-19 06:00:10 | INFO | train_inner | epoch 045:    250 / 324 loss=2.069, nll_loss=0.213, ppl=1.16, wps=19966.7, ups=5.14, wpb=3885.2, bsz=294.5, num_updates=14500, lr=4.20181e-06, gnorm=0.431, loss_scale=2, train_wall=19, wall=3381
2021-01-19 06:00:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:00:24 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:00:24 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:00:25 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:00:25 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:00:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 06:00:26 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:00:29 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c) which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 06:00:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:00:29 | INFO | valid | epoch 045 | valid on 'valid' subset | loss 4.153 | nll_loss 2.521 | ppl 5.74 | bleu 43.15 | wps 880.9 | wpb 1083 | bsz 37.8 | num_updates 14574 | best_loss 3.624
2021-01-19 06:00:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:00:35 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 45 @ 14574 updates, score 4.153) (writing took 6.672991389874369 seconds)
2021-01-19 06:00:35 | INFO | fairseq_cli.train | end of epoch 45 (average epoch stats below)
2021-01-19 06:00:35 | INFO | train | epoch 045 | loss 2.06 | nll_loss 0.203 | ppl 1.15 | wps 16761.6 | ups 4.37 | wpb 3838.4 | bsz 290.1 | num_updates 14574 | lr 4.19112e-06 | gnorm 0.389 | loss_scale 2 | train_wall 62 | wall 3407
2021-01-19 06:00:35 | INFO | fairseq_cli.train | begin training epoch 45
2021-01-19 06:00:40 | INFO | train_inner | epoch 046:     26 / 324 loss=2.055, nll_loss=0.197, ppl=1.15, wps=12380, ups=3.25, wpb=3814.2, bsz=284.5, num_updates=14600, lr=4.18739e-06, gnorm=0.364, loss_scale=2, train_wall=19, wall=3412
2021-01-19 06:01:00 | INFO | train_inner | epoch 046:    126 / 324 loss=2.06, nll_loss=0.204, ppl=1.15, wps=19872.2, ups=5.13, wpb=3870.6, bsz=293.1, num_updates=14700, lr=4.17312e-06, gnorm=0.385, loss_scale=2, train_wall=19, wall=3431
2021-01-19 06:01:19 | INFO | train_inner | epoch 046:    226 / 324 loss=2.063, nll_loss=0.206, ppl=1.15, wps=19719.8, ups=5.19, wpb=3799.9, bsz=286.1, num_updates=14800, lr=4.159e-06, gnorm=0.426, loss_scale=2, train_wall=19, wall=3450
2021-01-19 06:01:38 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:01:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:01:39 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:01:39 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:01:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:01:40 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 06:01:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:01:43 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 06:01:43 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:01:43 | INFO | valid | epoch 046 | valid on 'valid' subset | loss 4.15 | nll_loss 2.518 | ppl 5.73 | bleu 42.63 | wps 892 | wpb 1083 | bsz 37.8 | num_updates 14898 | best_loss 3.624
2021-01-19 06:01:43 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:01:50 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 46 @ 14898 updates, score 4.15) (writing took 6.941921589896083 seconds)
2021-01-19 06:01:50 | INFO | fairseq_cli.train | end of epoch 46 (average epoch stats below)
2021-01-19 06:01:50 | INFO | train | epoch 046 | loss 2.059 | nll_loss 0.202 | ppl 1.15 | wps 16688 | ups 4.35 | wpb 3838.4 | bsz 290.1 | num_updates 14898 | lr 4.1453e-06 | gnorm 0.389 | loss_scale 2 | train_wall 62 | wall 3481
2021-01-19 06:01:50 | INFO | fairseq_cli.train | begin training epoch 46
2021-01-19 06:01:50 | INFO | train_inner | epoch 047:      2 / 324 loss=2.058, nll_loss=0.2, ppl=1.15, wps=12465.3, ups=3.21, wpb=3878.9, bsz=296.1, num_updates=14900, lr=4.14502e-06, gnorm=0.383, loss_scale=2, train_wall=19, wall=3482
2021-01-19 06:02:10 | INFO | train_inner | epoch 047:    102 / 324 loss=2.054, nll_loss=0.196, ppl=1.15, wps=19664.5, ups=5.17, wpb=3801.6, bsz=284.4, num_updates=15000, lr=4.13118e-06, gnorm=0.371, loss_scale=2, train_wall=19, wall=3501
2021-01-19 06:02:29 | INFO | train_inner | epoch 047:    202 / 324 loss=2.062, nll_loss=0.206, ppl=1.15, wps=19844.8, ups=5.14, wpb=3857.9, bsz=292.3, num_updates=15100, lr=4.11748e-06, gnorm=0.391, loss_scale=2, train_wall=19, wall=3520
2021-01-19 06:02:48 | INFO | train_inner | epoch 047:    302 / 324 loss=2.061, nll_loss=0.204, ppl=1.15, wps=19941.3, ups=5.17, wpb=3859.6, bsz=295, num_updates=15200, lr=4.10391e-06, gnorm=0.394, loss_scale=2, train_wall=19, wall=3540
2021-01-19 06:02:53 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:02:53 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:02:53 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:02:54 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:02:54 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:02:55 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 06:02:55 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:02:57 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a study with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the concentration of a substance called glycosylated haemoglobin (HbA1c) which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 06:02:57 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:02:57 | INFO | valid | epoch 047 | valid on 'valid' subset | loss 4.163 | nll_loss 2.532 | ppl 5.78 | bleu 42.75 | wps 884.3 | wpb 1083 | bsz 37.8 | num_updates 15222 | best_loss 3.624
2021-01-19 06:02:57 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:03:03 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 47 @ 15222 updates, score 4.163) (writing took 5.681476110126823 seconds)
2021-01-19 06:03:03 | INFO | fairseq_cli.train | end of epoch 47 (average epoch stats below)
2021-01-19 06:03:03 | INFO | train | epoch 047 | loss 2.058 | nll_loss 0.201 | ppl 1.15 | wps 16976.3 | ups 4.42 | wpb 3838.4 | bsz 290.1 | num_updates 15222 | lr 4.10095e-06 | gnorm 0.38 | loss_scale 2 | train_wall 62 | wall 3554
2021-01-19 06:03:03 | INFO | fairseq_cli.train | begin training epoch 47
2021-01-19 06:03:18 | INFO | train_inner | epoch 048:     78 / 324 loss=2.06, nll_loss=0.204, ppl=1.15, wps=12777.4, ups=3.36, wpb=3803.6, bsz=287.2, num_updates=15300, lr=4.09048e-06, gnorm=0.385, loss_scale=2, train_wall=19, wall=3569
2021-01-19 06:03:38 | INFO | train_inner | epoch 048:    178 / 324 loss=2.055, nll_loss=0.198, ppl=1.15, wps=19560.9, ups=5.11, wpb=3825.1, bsz=288, num_updates=15400, lr=4.07718e-06, gnorm=0.352, loss_scale=2, train_wall=19, wall=3589
2021-01-19 06:03:57 | INFO | train_inner | epoch 048:    278 / 324 loss=2.056, nll_loss=0.199, ppl=1.15, wps=19680.8, ups=5.09, wpb=3864, bsz=297, num_updates=15500, lr=4.064e-06, gnorm=0.39, loss_scale=2, train_wall=19, wall=3609
2021-01-19 06:04:06 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:04:07 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:04:07 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:04:08 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:04:08 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:04:09 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy and is usually reversible.
2021-01-19 06:04:09 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:04:11 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapid was investigated in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a study with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapid.
2021-01-19 06:04:11 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:04:11 | INFO | valid | epoch 048 | valid on 'valid' subset | loss 4.162 | nll_loss 2.531 | ppl 5.78 | bleu 42.01 | wps 863.3 | wpb 1083 | bsz 37.8 | num_updates 15546 | best_loss 3.624
2021-01-19 06:04:11 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:04:18 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 48 @ 15546 updates, score 4.162) (writing took 6.544049729593098 seconds)
2021-01-19 06:04:18 | INFO | fairseq_cli.train | end of epoch 48 (average epoch stats below)
2021-01-19 06:04:18 | INFO | train | epoch 048 | loss 2.058 | nll_loss 0.201 | ppl 1.15 | wps 16662.8 | ups 4.34 | wpb 3838.4 | bsz 290.1 | num_updates 15546 | lr 4.05799e-06 | gnorm 0.377 | loss_scale 2 | train_wall 63 | wall 3629
2021-01-19 06:04:18 | INFO | fairseq_cli.train | begin training epoch 48
2021-01-19 06:04:28 | INFO | train_inner | epoch 049:     54 / 324 loss=2.061, nll_loss=0.204, ppl=1.15, wps=12291, ups=3.23, wpb=3808, bsz=284.9, num_updates=15600, lr=4.05096e-06, gnorm=0.402, loss_scale=2, train_wall=19, wall=3640
2021-01-19 06:04:48 | INFO | train_inner | epoch 049:    154 / 324 loss=2.056, nll_loss=0.2, ppl=1.15, wps=19695.2, ups=5.09, wpb=3871.4, bsz=295.4, num_updates=15700, lr=4.03804e-06, gnorm=0.363, loss_scale=2, train_wall=19, wall=3659
2021-01-19 06:05:08 | INFO | train_inner | epoch 049:    254 / 324 loss=2.056, nll_loss=0.198, ppl=1.15, wps=19395.6, ups=5.1, wpb=3805.4, bsz=282.8, num_updates=15800, lr=4.02524e-06, gnorm=0.381, loss_scale=2, train_wall=19, wall=3679
2021-01-19 06:05:21 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:05:22 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:05:22 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:05:23 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:05:23 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:05:24 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms called acute painful neuropathy and is usually reversible.
2021-01-19 06:05:24 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:05:26 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes, in whom the pancreas is unable to produce insulin (two studies with 1,954 patients), and in patients with type 2 diabetes, in whom the body is unable to process insulin effectively (a study with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has UNKNOWNTOKENINHYP Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6-month treatment with Actrapide.
2021-01-19 06:05:26 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:05:26 | INFO | valid | epoch 049 | valid on 'valid' subset | loss 4.178 | nll_loss 2.551 | ppl 5.86 | bleu 42.15 | wps 895.3 | wpb 1083 | bsz 37.8 | num_updates 15870 | best_loss 3.624
2021-01-19 06:05:26 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:05:33 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 49 @ 15870 updates, score 4.178) (writing took 6.904645217116922 seconds)
2021-01-19 06:05:33 | INFO | fairseq_cli.train | end of epoch 49 (average epoch stats below)
2021-01-19 06:05:33 | INFO | train | epoch 049 | loss 2.057 | nll_loss 0.2 | ppl 1.15 | wps 16499.7 | ups 4.3 | wpb 3838.4 | bsz 290.1 | num_updates 15870 | lr 4.01635e-06 | gnorm 0.38 | loss_scale 2 | train_wall 63 | wall 3704
2021-01-19 06:05:33 | INFO | fairseq_cli.train | begin training epoch 49
2021-01-19 06:05:39 | INFO | train_inner | epoch 050:     30 / 324 loss=2.056, nll_loss=0.198, ppl=1.15, wps=12377.8, ups=3.19, wpb=3881.3, bsz=291.7, num_updates=15900, lr=4.01256e-06, gnorm=0.363, loss_scale=2, train_wall=20, wall=3710
2021-01-19 06:05:58 | INFO | train_inner | epoch 050:    130 / 324 loss=2.061, nll_loss=0.205, ppl=1.15, wps=20013.3, ups=5.14, wpb=3895.1, bsz=299.4, num_updates=16000, lr=4e-06, gnorm=0.398, loss_scale=2, train_wall=19, wall=3730
2021-01-19 06:06:18 | INFO | train_inner | epoch 050:    230 / 324 loss=2.051, nll_loss=0.193, ppl=1.14, wps=19524.9, ups=5.17, wpb=3777.5, bsz=281.2, num_updates=16100, lr=3.98756e-06, gnorm=0.355, loss_scale=2, train_wall=19, wall=3749
2021-01-19 06:06:36 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-01-19 06:06:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide contains metacresol, which may cause allergic reactions.
2021-01-19 06:06:37 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-01-19 06:06:37 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide is fast-acting insulin and can be used together with long-acting insulin products.
2021-01-19 06:06:37 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-01-19 06:06:38 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with symptoms called acute painful neuropathy and is usually reversible.
2021-01-19 06:06:38 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-01-19 06:06:41 | INFO | fairseq.tasks.translation | example hypothesis: UNKNOWNTOKENINHYP Actrapide was investigated in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two trials with 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a trial with 182 patients). UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Actrapide was compared with a human insulin analogue (insulin Aspart) by measuring in blood for six months the levels of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled. UNKNOWNTOKENINHYP What benefit has Actrapid shown in these trials? UNKNOWNTOKENINHYP UNKNOWNTOKENINHYP Concentrations of HbA1c remained relatively stable during 6 months of treatment with Actrapide.
2021-01-19 06:06:41 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-01-19 06:06:41 | INFO | valid | epoch 050 | valid on 'valid' subset | loss 4.174 | nll_loss 2.547 | ppl 5.85 | bleu 41.99 | wps 889.3 | wpb 1083 | bsz 37.8 | num_updates 16194 | best_loss 3.624
2021-01-19 06:06:41 | INFO | fairseq_cli.train | begin save checkpoint
2021-01-19 06:06:47 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_p_5/checkpoint_last.pt (epoch 50 @ 16194 updates, score 4.174) (writing took 6.372921913862228 seconds)
2021-01-19 06:06:47 | INFO | fairseq_cli.train | end of epoch 50 (average epoch stats below)
2021-01-19 06:06:47 | INFO | train | epoch 050 | loss 2.057 | nll_loss 0.2 | ppl 1.15 | wps 16816.2 | ups 4.38 | wpb 3838.4 | bsz 290.1 | num_updates 16194 | lr 3.97597e-06 | gnorm 0.38 | loss_scale 2 | train_wall 62 | wall 3778
2021-01-19 06:06:47 | INFO | fairseq_cli.train | done training in 3773.1 seconds


###############################################################################
Peregrine Cluster
Job 17437246 for user 's3475743'
Finished at: Tue Jan 19 06:06:50 CET 2021

Job details:
============

Job ID              : 17437246
Name                : EMEA_p_5
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu25
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-01-19T04:41:46
Start               : 2021-01-19T05:03:36
End                 : 2021-01-19T06:06:50
Reserved walltime   : 23:55:00
Used walltime       : 01:03:14
Used CPU time       : 01:08:44 (efficiency:  9.06%)
% User (Computation): 67.97%
% System (I/O)      : 32.04%
Mem reserved        : 32G/node
Max Mem used        : 5.61G (pg-gpu25)
Max Disk Write      : 40.96K (pg-gpu25)
Max Disk Read       : 2.30M (pg-gpu25)
Average GPU usage   : 81.1% (pg-gpu25)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/additional_information/scientific_output

################################################################################
